<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28939</article-id><article-id pub-id-type="doi">10.7554/eLife.28939</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Heg1 and Ccm1/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-89378"><name><surname>Donat</surname><given-names>Stefan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3901-3733</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-89385"><name><surname>Lourenço</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-89382"><name><surname>Paolini</surname><given-names>Alessio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7002-7303</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89383"><name><surname>Otten</surname><given-names>Cécile</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8230-7350</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89384"><name><surname>Renz</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-88941"><name><surname>Abdelilah-Seyfried</surname><given-names>Salim</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3183-3841</contrib-id><email>salim.seyfried@uni-potsdam.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Institute of Biochemistry and Biology</institution><institution>Potsdam University</institution><addr-line><named-content content-type="city">Potsdam</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Institute of Molecular Biology</institution><institution>Hannover Medical School</institution><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-10482"><name><surname>Yelon</surname><given-names>Deborah</given-names></name><role>Reviewing Editor</role><aff id="aff3"><institution>University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>02</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e28939</elocation-id><history><date date-type="received" iso-8601-date="2017-05-23"><day>23</day><month>05</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2018-01-24"><day>24</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Donat et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Donat et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-28939-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.28939.001</object-id><p>Endothelial cells respond to different levels of fluid shear stress through adaptations of their mechanosensitivity. Currently, we lack a good understanding of how this contributes to sculpting of the cardiovascular system. Cerebral cavernous malformation (CCM) is an inherited vascular disease that occurs when a second somatic mutation causes a loss of CCM1/KRIT1, CCM2, or CCM3 proteins. Here, we demonstrate that zebrafish Krit1 regulates the formation of cardiac valves. Expression of <italic>heg1</italic>, which encodes a binding partner of Krit1, is positively regulated by blood-flow. In turn, Heg1 stabilizes levels of Krit1 protein, and both Heg1 and Krit1 dampen expression levels of <italic>klf2a,</italic> a major mechanosensitive gene. Conversely, loss of Krit1 results in increased expression of <italic>klf2a</italic> and <italic>notch1b</italic> throughout the endocardium and prevents cardiac valve leaflet formation. Hence, the correct balance of blood-flow-dependent induction and Krit1 protein-mediated repression of <italic>klf2a</italic> and <italic>notch1b</italic> ultimately shapes cardiac valve leaflet morphology.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CCM</kwd><kwd>heart</kwd><kwd>cardiac valves</kwd><kwd>KLF2</kwd><kwd>endocardium</kwd><kwd>VE-cadherin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>Excellence Cluster REBIRTH</award-id><principal-award-recipient><name><surname>Donat</surname><given-names>Stefan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 958</award-id><principal-award-recipient><name><surname>Otten</surname><given-names>Cécile</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>Project number SE2016/7-2</award-id><principal-award-recipient><name><surname>Paolini</surname><given-names>Alessio</given-names></name><name><surname>Otten</surname><given-names>Cécile</given-names></name><name><surname>Renz</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>Project number SE2016/10-1</award-id><principal-award-recipient><name><surname>Paolini</surname><given-names>Alessio</given-names></name><name><surname>Otten</surname><given-names>Cécile</given-names></name><name><surname>Renz</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The cerebral cavernous malformations complex is controlled in a blood-flow sensitive manner and affects cardiac valve leaflet morphogenesis by regulating the expression of Klf2 and of Notch signalling activity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Biophysical forces including shear stress caused by blood-flow trigger activation of mechanotransduction pathways within endothelial cells (ECs), a process which causes cellular changes that contribute to the sculpting of vascular networks and of the heart (<xref ref-type="bibr" rid="bib1">Baeyens and Schwartz, 2016</xref>; <xref ref-type="bibr" rid="bib16">Haack and Abdelilah-Seyfried, 2016</xref>). Currently, our knowledge is incomplete regarding the modes by which the sensitivity of different vascular beds is attuned to the constantly changing stimulus of blood-flow. One well-studied example of a blood-flow-sensitive developmental process involves remodeling of endocardial cushions into cardiac valve leaflets in the zebrafish embryo (<xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Pestel et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Scherz et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). Prior to the formation of cardiac cushions, the oscillatory pattern of blood-flow induces expression of the mechanotransduction pathway components zinc-finger transcription factors Krüppel like factors 2a (<italic>klf2a</italic>) (<xref ref-type="bibr" rid="bib45">Vermot et al., 2009</xref>) and <italic>klf2b</italic> (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). <italic>KLF</italic>s are important blood-flow-responsive genes within ECs that are strongly activated within regions of high shear stress in tissue culture and various <italic>in vivo</italic> models (<xref ref-type="bibr" rid="bib8">Dekker et al., 2002</xref>, <xref ref-type="bibr" rid="bib9">2005</xref>; <xref ref-type="bibr" rid="bib14">Groenendijk et al., 2004</xref>, <xref ref-type="bibr" rid="bib15">2005</xref>; <xref ref-type="bibr" rid="bib23">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib33">Novodvorsky and Chico, 2014</xref>; <xref ref-type="bibr" rid="bib34">Parmar et al., 2005</xref>; <xref ref-type="bibr" rid="bib56">Zhou et al., 2016</xref>). As zebrafish cardiac atrioventricular (AV) cushions are remodeled into AV valve leaflets, endocardial <italic>klf2a</italic> is highly expressed on the luminal side of the developing valve leaflet, which is exposed to blood-flow, whereas its expression is low on the abluminal side of the leaflet (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). Zebrafish <italic>klf2a</italic> mutants exhibit defective cardiac valve leaflets (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) and a loss of murine <italic>Klf2</italic> also results in atrioventricular cushion defects (<xref ref-type="bibr" rid="bib6">Chiplunkar et al., 2013</xref>). One of the targets of <italic>klf2a</italic> within cardiac cushions is <italic>notch1b</italic> (<xref ref-type="bibr" rid="bib45">Vermot et al., 2009</xref>). The precise spatiotemporal regulation of <italic>Klf2</italic> expression within cardiac valve leaflets indicates that fine-tuning the response to blood-flow has a conserved role in shaping functional leaflets during cardiac morphogenesis.</p><p>The control of <italic>Klf2</italic> expression has been linked to the cerebral cavernous malformations protein complex (<xref ref-type="bibr" rid="bib28">Maddaluno et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Zhou et al., 2015</xref>, <xref ref-type="bibr" rid="bib56">2016</xref>). Within this complex, KRIT1 (also known as CCM1) and the transmembrane protein HEG1 (also known as Heart of glass) physically interact with each other. This interaction results in stabilization of both proteins at EC junctions (<xref ref-type="bibr" rid="bib13">Gingras et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">Kleaveland et al., 2009</xref>). The loss of HEG1, KRIT1, CCM2, or PDCD10 (also referred to as CCM3) causes severe cardiovascular and cardiac developmental defects (<xref ref-type="bibr" rid="bib21">Kleaveland et al., 2009</xref>; <xref ref-type="bibr" rid="bib25">Mably et al., 2003</xref>; <xref ref-type="bibr" rid="bib26">Mably et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">Whitehead et al., 2009</xref>; <xref ref-type="bibr" rid="bib51">Yoruk et al., 2012</xref>; <xref ref-type="bibr" rid="bib53">Zheng et al., 2010</xref>). However, functional studies in zebrafish suggest that Ccm3 functions in a manner that is separate from Krit1 and Ccm2 (<xref ref-type="bibr" rid="bib51">Yoruk et al., 2012</xref>). The name CCM refers to pathologies with familial inheritance that have been attributed to mutations in human <italic>KRIT1</italic>, <italic>CCM2</italic>, or <italic>PDCD10</italic>. Affected individuals exhibit morphological malformations of low-perfused venous endothelial beds of the neuro-vasculature that can result in dangerous cerebral bleeding [reviewed in <xref ref-type="bibr" rid="bib37">Riant et al., 2010</xref>]. Similarly, the conditional endothelial-specific loss of <italic>Krit1</italic>, <italic>Ccm2</italic>, or <italic>Pdcd10</italic> in postnatal mice causes CCM lesions (<xref ref-type="bibr" rid="bib4">Boulday et al., 2011</xref>; <xref ref-type="bibr" rid="bib5">Chan et al., 2011</xref>). Strikingly, postnatal loss of <italic>Heg1</italic> in mice does not cause CCM lesions and familial forms of the CCM pathology have never been associated with mutations in <italic>HEG1</italic> (<xref ref-type="bibr" rid="bib54">Zheng et al., 2014</xref>). These findings suggest a developmental role for HEG1-CCM signaling which differs from postnatal functions of the other CCM proteins.</p><p>Functional studies in zebrafish <italic>ccm</italic> and murine <italic>Ccm</italic> mutants have linked cardiovascular developmental defects to elevated expression levels of <italic>Klf2</italic> (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Zhou et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">2016</xref>). Two major pathways have been implicated in regulation of <italic>KLF2</italic> by the CCM proteins KRIT1 and CCM2. First, the core adaptor protein KRIT1 and its associated β1-Integrin binding protein 1 (ICAP1) suppress β1-Integrin signaling in human umbilical vein endothelial cells (HUVECs) (<xref ref-type="bibr" rid="bib12">Faurobert et al., 2013</xref>). A loss either of CCM proteins or of ICAP1 enhances Integrin signaling and this causes strong upregulation of <italic>KLF2</italic> expression in HUVECs, which is suppressed by the depletion of β1-Integrin (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). Similarly in zebrafish, <italic>ccm</italic> mutant cardiovascular defects are suppressed by a knockdown of β1-Integrin (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). Secondly, the binding of CCM2 to MEKK3 (also known as MAP3K3) (<xref ref-type="bibr" rid="bib7">Cullere et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Uhlik et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">Zhou et al., 2015</xref>) inhibits the MEKK3-MEK5-ERK5 mechanotransduction pathway, which controls expression levels of murine <italic>Klf2</italic> (<xref ref-type="bibr" rid="bib55">Zhou et al., 2015</xref>). These findings point to the importance of CCM proteins in regulating the physiological responsiveness of ECs to blood-flow. In support of such a physiological role, CCM proteins antagonize activation of β1-Integrin and thus interfere with the orientation of endothelial cells in response to shear stress (<xref ref-type="bibr" rid="bib27">Macek Jilkova et al., 2014</xref>).</p><p>The developmental connection of Ccm proteins with the regulation of <italic>klf2a</italic> expression led us to investigate whether expression of zebrafish <italic>heg1</italic> and <italic>krit1</italic> within the vasculature is controlled in a mechanosensitive manner. We find that expression of <italic>heg1</italic> is positively regulated in response to blood-flow and <italic>klf2a/b</italic>. We also explored the role of Heg1 and Krit1 in Klf2-dependent endothelial mechanotransduction during the formation of cardiac valve leaflets. Here, we show that Krit1 dampens levels of <italic>klf2a</italic> and <italic>notch1b</italic> expression. In tune with this finding, loss of Krit1 results in strong expression of <italic>klf2a</italic> and <italic>notch1b</italic> within the endocardium and prevents formation of an abluminal population of valve leaflet cells from endocardial cushions. Our findings reveal an important developmental role of Ccm proteins in fine-tuning the sensitivity of ECs in response to the strength of the biomechanical stimulus of blood-flow during valvulogenesis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Expression levels of <italic>heg1</italic> mRNA are positively regulated by blood-flow and Klf2a/b</title><p>To test whether the regulation of <italic>heg1</italic> or <italic>krit1</italic> mRNAs responds to changes in blood-flow, we measured their expression levels using RT-qPCR in <italic>troponin T type 2a</italic> (<italic>tnnt2a</italic>) morphants that have a non-contractile heart and thus lack blood-flow (<xref ref-type="bibr" rid="bib42">Sehnert et al., 2002</xref>). Under this condition, mRNA levels of <italic>heg1</italic> but not of <italic>krit1</italic> were significantly lower than in wild-type (WT) embryos at 54 hr post fertilization (hpf) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Similarly, antisense oligonucleotide morpholino (MO)-mediated knockdown of Klf2a/b caused significant downregulation of <italic>heg1</italic> mRNA. In comparison, the expression levels of <italic>krit1</italic> mRNA were not significantly altered (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To test whether <italic>heg1</italic> is positively regulated by Klf2a, we generated transgenic lines of zebrafish for heat-shock-mediated induction of <italic>klf2a</italic> [<italic>Tg(hsp70l:klf2a_IRES_EGFP)<sup>pbb22</sup></italic>]. We found that overexpression of <italic>klf2a</italic> upon heat-shock at 48–50 hpf led to a significant upregulation of <italic>heg1</italic> mRNA expression by 54–55 hpf (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). However, the treatment did not significantly upregulate levels of <italic>krit1</italic> mRNA.</p><p>It has previously been shown that <italic>heg1</italic> is expressed within endocardium (<xref ref-type="bibr" rid="bib25">Mably et al., 2003</xref>). To determine the regional expression of <italic>heg1</italic> mRNA within the endocardium, we performed whole-mount <italic>in situ</italic> hybridizations in WT and <italic>tnnt2a</italic> morphants. Whereas <italic>heg1</italic> was initially expressed throughout the entire endocardium at 30 hpf, by 48 hpf, expression became more restricted to cells exposed to a high fluid shear stress including the atrioventricular canal (AVC) endocardium, and this was even more striking at 72 hpf [<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C</xref>; (<xref ref-type="bibr" rid="bib30">Münch et al., 2017</xref>)]. In tune with flow-dependent regulation within the endocardium, expression of <italic>heg1</italic> mRNA was reduced in <italic>tnnt2a</italic> morphants at 48 hpf (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>).</p><p>As Heg1 and Krit1 proteins are known to interact <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib21">Kleaveland et al., 2009</xref>), we next tested whether Heg1 protein affects protein levels of its binding partner Krit1. To this end, we first generated a transgenic line of zebrafish for expression of EGFP-Krit1 [<italic>Tg(UAS:EGFP-krit1)<sup>pbb21</sup></italic>]. Next, we analyzed the levels of EGFP-Krit1 protein in <italic>heg1</italic> MO-injected embryos and found that they were significantly lower than in WT control embryos in the heart (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>) and the caudal vasculature at 30 hpf (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Taken together, the levels of <italic>heg1</italic> mRNA expression are positively regulated by blood-flow and Klf2a-dependent mechanotransduction. In turn, Heg1 has a stabilizing effect on Krit1 levels.</p></sec><sec id="s2-2"><title>Overexpression of <italic>heg1</italic> or <italic>krit1</italic> mRNA dampens expression levels of <italic>klf2a</italic> mRNA</title><p>A loss of Ccm proteins in zebrafish or mice results in higher levels of <italic>klf2</italic> mRNA expression, suggesting that the physiological role of Ccm proteins is to modulate <italic>klf2</italic> expression levels in response to blood-flow (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Zhou et al., 2015</xref>, <xref ref-type="bibr" rid="bib56">2016</xref>). Given that levels of <italic>heg1</italic> mRNA expression are affected by blood-flow, we explored whether upregulation of Heg1 or Krit1 would have an impact on endothelial mechanotransduction pathways. First, we injected <italic>heg1</italic> mRNA at the one-cell stage and assessed <italic>klf2a</italic> mRNA levels at 24 and 48 hpf. At both times, high levels of <italic>heg1</italic> mRNA correlated with significantly lower levels of <italic>klf2a</italic> expression (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Next, we tested whether overexpression of <italic>krit1</italic> also downregulates levels of <italic>klf2a</italic> mRNA by using a transgenic line with heat-shock-inducible <italic>krit1</italic> [<italic>Tg(hsp70l:krit1_IRES EGFP)<sup>md6</sup></italic>]. Treatment with multiple heat-shocks at 14, 24, and 40 hpf resulted in significant downregulation of <italic>klf2a</italic> mRNA levels throughout the entire embryo at 48 hpf as determined by RT-qPCR (<italic>klf2a</italic>: fold change 0.63, p&lt;0.05, n = 4 replicates; <italic>krit1</italic>: fold change 9.77, p&lt;0.001, n = 4 replicates). Cardiac cushions formed normally after this treatment (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) and blood-flow was not affected as assessed by visual inspection (n &gt; 100 embryos analyzed showed normal blood circulation). Hence, the forced upregulation of <italic>heg1</italic> or <italic>krit1</italic> dampens expression levels of <italic>klf2a</italic> mRNA. This finding suggests that the strength of the biomechanical forces resulting from blood-flow impacts the expression levels of Ccm proteins; this modulates mechanosensitive signaling within endothelial cells upstream of <italic>klf2a</italic>.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.28939.002</object-id><label>Figure 1.</label><caption><title>Mechanosensitive expression of <italic>heg1</italic> mRNA and stabilization of Krit1 protein levels by <italic>heg1</italic>.</title><p>(<bold>A</bold>) RT-qPCR quantifications of <italic>heg1</italic> and <italic>krit1</italic> mRNA levels at 54 hpf in morphant embryos lacking blood-flow [<italic>troponin T type 2a</italic> (<italic>tnnt2a</italic>)], or Krüppel like factors 2a and 2b (<italic>klf2a/b</italic>) compared with wild-type expression levels. (<bold>B</bold>) RT-qPCR quantification showing that heat-shock-induced overexpression of <italic>klf2a</italic> causes significant upregulation of <italic>heg1</italic> but not of <italic>krit1</italic> expression at 54 hpf. (<bold>C–E</bold>) Morpholino-mediated knockdown of Heg1 significantly reduces endocardial EGFP-Krit1 protein levels of 30 hpf <italic>Tg(fli:GAL4FF)<sup>ubs3</sup></italic>; <italic>Tg(UAS:EGFP-Krit1)<sup>pbb21</sup></italic> embryos. Scale bars are 50 µm. Mean values ± SEM of three (<italic>tnnt2a</italic> MO, <italic>hs:klf2a</italic>, <italic>heg1</italic> MO) or four (<italic>klf2a/b</italic> MO) individual experiments are shown. Ratio paired (<bold>A, B</bold>) or unpaired (<bold>E</bold>) t-test was used to compare each condition with controls (ns: not significant, *p&lt;0.05, ***p&lt;0.001).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Whole-mount <italic>in situ</italic> hybridization of <italic>heg1</italic> cardiac expression.</title><p>(<bold>A</bold>) At 30 hpf, <italic>heg1</italic> is expressed throughout the entire endocardium. (<bold>B</bold>) Later, at 48 hpf, <italic>heg1</italic> expression becomes restricted to high fluid shear stress regions of the endocardium including the atrioventricular canal (AVC). (<bold>C</bold>) The strong expression of <italic>heg1</italic> at the AVC persists at 72 hpf. (<bold>D</bold>) Expression of <italic>heg1</italic> was reduced in morphant embryos lacking blood-flow [<italic>troponin T type 2a</italic> (<italic>tnnt2a</italic>)] at 48 hpf. A: atrium, V: ventricle, OFT: outflow tract, arrowheads in B, C, and D point at the AVC.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Stabilization of Krit1 protein levels by <italic>heg1</italic> in the trunk vasculature.</title><p>(<bold>A–C</bold>) Morpholino-mediated knockdown of Heg1 significantly reduces EGFP-Krit1 protein levels in the trunk vasculature of 30 hpf <italic>Tg(fli:GAL4FF)<sup>ubs3</sup></italic>; <italic>Tg(UAS:EGFP-Krit1)<sup>pbb21</sup></italic> embryos. Scale bars are 50 µm. Mean values ± SEM of three individual experiments are shown. Unpaired t-test was used to compare conditions with control (****p&lt;0.0001).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig1-figsupp2-v2"/></fig></fig-group><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.28939.005</object-id><label>Figure 2.</label><caption><title>Desensitization of endocardial cells to blood-flow by <italic>heg1</italic>, <italic>krit1,</italic> or <italic>ccm2</italic> overexpression.</title><p>(<bold>A</bold>) Correlation of high <italic>heg1</italic> and low <italic>klf2a</italic> mRNA expression levels at 24 and 48 hpf as determined by RT-qPCR. (<bold>B–D</bold>) Projections of confocal z-stack images of 54 hpf hearts expressing the flow-responsive marker <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> in heat-shocked wild-type (WT) (<bold>B</bold>), heat-shock- (hs) induced <italic>krit1</italic> overexpression (<bold>C</bold>), and hs-induced <italic>ccm2</italic> overexpression (<bold>D</bold>). (<bold>E</bold>) Different ratios of corrected total tissue fluorescence (CTTF) of atrial versus ventricular (+atrioventricular canal region (AVC), arrowhead) expression of the flow-responsive marker <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> between 54 hpf WT and <italic>krit1</italic>-overexpressing hearts (n = 37) and WT and <italic>ccm2</italic>-overexpressing hearts (n = 39). <italic>krit1-</italic> or <italic>ccm2-</italic>overexpression results in more equal chamber expression of flow-responsive marker <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> expression (depicted is a WT heart corresponding to the <italic>krit1</italic>-overexpression experiment). (<bold>F</bold>) Fold change of relative fluorescence (CTTF) in the AVC of <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> in <italic>krit1</italic>- and <italic>ccm2</italic>- overexpressing hearts versus the corresponding controls. Scale bars are 50 µm. Mean values ± SEM are shown. Unpaired t-test was used to compare each condition with the WT (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Exclusive endocardial expression of the Notch reporter <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> and cardiac cushions forming normally on overexpression of <italic>krit1</italic> and <italic>ccm2</italic>.</title><p>(<bold>A–C</bold>) (<bold>A</bold>) Maximum projections of confocal z-stacks of 48 hpf heat-shocked wild-type (WT) embryo, (<bold>B</bold>) heat-shock-induced (hs) <italic>krit1</italic> overexpressing embryo, and (<bold>C</bold>) hs-induced <italic>ccm2</italic> overexpressing embryo. Myocardial cells and endocardial cushions are stained for Alcam (Magenta). Myocardial cells do not express the destabilized Notch reporter <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> (yellow), which is expressed within endocardium and endocardial cushions. (<bold>A’–C’</bold>) Shown are projections of 3 confocal z-stack planes (1 μm each) of the same hearts as shown in (<bold>A–C</bold>). (<bold>A’’–C”’</bold>) Single confocal z-section images of the atrioventricular canal (AVC) region highlighted with a white square in the panels D-F. (<bold>A’’’–C’’’</bold>) Inverted images of Notch reporter shown in A’’-C’’ (asterisks mark endocardial cushion cells). Note dowregulation of Notch activity on Krit1 and Ccm2 overexpression (<bold>B, C, B’–C’’’</bold>). The morphology of endocardial cushions remains unaltered on <italic>krit1</italic> and <italic>ccm2</italic> overexpression at this stage (<bold>B’’–C’’</bold>). A: atrium, V: ventricle, arrowheads point at the AVC. Scale bars are 50 µm in A-F and 10 µm in D’-F’’.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig2-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-3"><title>Krit1 and Ccm2 impact expression of the mechanosensitive Notch activity reporter <italic>Tg(TP1:VenusPEST)</italic></title><p>To further assess the physiological effects of altered levels of CCM proteins for endocardial patterning, we analyzed expression levels of the transgenic line <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic>, which expresses destabilized Venus protein in regions of strong Notch activity (<xref ref-type="bibr" rid="bib32">Ninov et al., 2012</xref>). In zebrafish, <italic>notch1b</italic> is a blood-flow-responsive gene that is highly expressed at cardiac cushions (<xref ref-type="bibr" rid="bib45">Vermot et al., 2009</xref>). By 54 hpf, the expression of <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> is restricted to the ventricular chamber and is particularly strong within the AVC region (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). To induce upregulation of <italic>krit1</italic> or <italic>ccm2</italic>, <italic>Tg(hsp70l:krit1_IRES EGFP)<sup>md6</sup></italic> or <italic>Tg(hsp70l:ccm2_IRES EGFP)<sup>md12</sup></italic> embryos were treated with multiple heat-shocks at 14, 24, 40, and 48 hpf. On <italic>krit1</italic> or <italic>ccm2</italic> overexpression, and consistent with a dampening of blood-flow responses, expression from the <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> reporter was generally weakened and was not restricted to the ventricle and AVC region at 54 hpf (<xref ref-type="fig" rid="fig2">Figure 2B–F</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Hence, overexpression of <italic>krit1</italic> or <italic>ccm2</italic> affects the expression levels and pattern of the <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> reporter, which is responsive to blood-flow within the heart. Notably, the expression of this Notch reporter was exclusively endocardial in all of these experimental conditions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). This result suggests that endocardial cells become desensitized to blood-flow-induced mechanosensitive signaling when <italic>krit1</italic> or <italic>ccm2</italic> are overexpressed.</p></sec><sec id="s2-4"><title>Krit1 is required for generation of abluminal cell fates during valvulogenesis</title><p>Given the strong involvement of Ccm proteins in mechanotransduction pathways, we next explored whether they have a developmental role during remodeling of cardiac cushions into valve leaflets, a morphogenetic process that is highly sensitive to the biomechanical stimulus of blood-flow (<xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Pestel et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Scherz et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Vermot et al., 2009</xref>). Previously, it was not possible to address such a potential developmental role as zebrafish <italic>ccm</italic> mutant endocardial cells fail to form cardiac cushions [<xref ref-type="fig" rid="fig3">Figure 3B</xref>; (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). This is in contrast to WT endocardial cushion cells that acquire cuboidal shapes at 48 hpf and express activated leukocyte cell adhesion molecule (Alcam) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>). To elucidate whether CCM proteins play a role in this process, we performed a rescue experiment by injecting mRNA encoding EGFP-Krit1 into <italic>krit1<sup>ty219c</sup></italic> mutants, which rescued the cardiovascular defects associated with the loss of Krit1 at 48 hpf (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Zebrafish <italic>ccm</italic> mutants have increased endocardial cell numbers by 48 hpf (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). To determine whether injection of mRNA encoding EGFP-Krit1 into <italic>krit1<sup>ty219c</sup></italic> mutants could rescue endocardial cell numbers, we compared ventricular endocardial cell numbers of WT and <italic>krit1<sup>ty219c</sup></italic> rescued embryos at 48 and 55 hpf (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Consistent with the strong rescue of the <italic>krit1<sup>ty219c</sup></italic> mutant phenotype at 48 hpf, the number of ventricular endocardial cells was normal at this stage. However, by 55 hpf, ventricular endocardial cell numbers had increased beyond those in WT, which suggests that at this stage the <italic>krit1<sup>ty219c</sup></italic> mutant phenotype becomes expressed again. To assay whether the re-appearance of a late <italic>krit1<sup><italic>ty219c</italic></sup></italic> mutant phenotype correlated with decreasing <italic>egfp-krit1</italic> mRNA levels, we monitored <italic>krit1</italic> mRNA levels over time using RT-qPCR. Indeed, WT embryos injected with <italic>egfp-krit1</italic> mRNA showed a significant decrease of <italic>krit1</italic> mRNA levels between 24 and 96 hpf (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). This result is consistent with recurrence of the <italic>krit1<sup>ty219c</sup></italic> mutant phenotype at 55 hpf.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.28939.007</object-id><label>Figure 3.</label><caption><title>Krit1 is required for abluminal cell fates during valvulogenesis.</title><p>(<bold>A–F</bold>) Single confocal z-section images of endocardial cells within the atrioventricular canal (AVC) region marked by <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> expression (cyan) and Alcam staining (magenta). (<bold>A</bold>) At 48 hpf, wild-type (WT) endocardial cushion cells express Alcam (asterisks). (<bold>B</bold>) In <italic>krit1<sup>ty219c</sup></italic> mutants, endocardial cells of the AVC region do not express Alcam and cushions do not form (arrow). (<bold>C</bold>) Injection of <italic>egfp-krit1</italic> mRNA rescues cardiac cushion formation in <italic>krit1<sup>ty219c</sup></italic> mutants (n = 15/15). <italic>krit1<sup>ty219c</sup></italic> mutant hearts form cardiac cushions and endocardial cushion cells express Alcam. (<bold>D</bold>) By 96 hpf, Alcam expression is mainly restricted to luminal endocardial cells of the developing WT cardiac valve leaflet (asterisks). (<bold>E</bold>) <italic>krit1<sup>ty219c</sup></italic> mutants do not form valve leaflets but AVC endocardial cells express Alcam (asterisks). (<bold>F</bold>) <italic>krit1<sup>ty219c</sup></italic> mutant that was initially rescued by <italic>egfp-krit1</italic> mRNA injection has a dysmorphic cardiac valve leaflet at 96 hpf with an agglomeration of luminal Alcam-positive cells (asterisks). (<bold>G–L</bold>) Whole-mount <italic>in situ</italic> hybridization of <italic>klf2a</italic> cardiac expression. (<bold>G</bold>) At 54 hpf, <italic>klf2a</italic> expression is restricted to endocardial cells of the AVC in WT while (<bold>H</bold>) <italic>klf2a</italic> is strongly expressed throughout the entire endocardium in <italic>krit1<sup>ty219c</sup></italic> mutant. (<bold>I</bold>) <italic>krit1<sup>ty219c</sup></italic> mutant rescued by injection of <italic>egfp-krit1</italic> mRNA has a restricted and strong <italic>klf2a</italic> expression at the AVC (n = 6/6). (<bold>J</bold>) By 96 hpf, <italic>klf2a</italic> expression is restricted to the AVC in WT while (<bold>K</bold>) <italic>klf2a</italic> is strongly expressed throughout the entire endocardium in <italic>krit1<sup>ty219c</sup></italic> mutants. (<bold>L</bold>) <italic>krit1<sup>ty219c</sup></italic> mutant embryo injected with <italic>egfp-krit1</italic> mRNA has high <italic>klf2a</italic> levels throughout the entire endocardium (n = 8/8). A: atrium, V: ventricle, L: luminal, AL: abluminal. Scale bars are 10 μm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Rescue of <italic>krit1<sup>ty219c</sup></italic> mutant cardiovascular phenotypes by injection of mRNA encoding EGPF-Krit1.</title><p>(<bold>A–C</bold>) Projections of confocal z-stack images of (<bold>A</bold>) 48 hpf wild-type (WT), (<bold>B</bold>) <italic>krit1<sup>ty219c</sup></italic> mutant, and (<bold>C</bold>) rescued <italic>krit1<sup>ty219c</sup></italic> mutant hearts marked by <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> expression. In comparison to WT, <italic>krit1<sup>ty219c</sup></italic> mutant hearts are dilated and lack the atrioventricular canal (AVC) (red arrowhead). (<bold>C</bold>) Injection of <italic>egfp-krit1</italic> mRNA into <italic>krit1<sup>ty219c</sup></italic> mutants rescues the <italic>krit1<sup>ty219c</sup></italic> mutant cardiac phenotype (n = 82/82 <italic>krit1<sup>ty219c</sup></italic> mutant embryos rescued). (<bold>D–F</bold>) Projections of confocal z-stack images of 48 hpf caudal plexus regions of the vasculature marked by <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> expression. (<bold>D</bold>) In comparison to the highly branched WT morphology of the caudal vein plexus (red asterisks), (<bold>E</bold>) the <italic>krit1<sup>ty219c</sup></italic> mutant vasculature has a fused morphology. (<bold>F</bold>) Injection of <italic>egfp-krit1</italic> mRNA into <italic>krit1<sup>ty219c</sup></italic> mutants rescues the <italic>krit1<sup>ty219c</sup></italic> mutant vascular phenotype including a highly branched WT-like caudal vein plexus (red asterisks). A: atrium, V: ventricle. Scale bars are 50 µm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig3-figsupp1-v2"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.009</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Injection of mRNA encoding EGFP-Krit1 into <italic>krit1<sup>ty219c</sup></italic> mutants prevents overgrowth of ventricular endocardial cells.</title><p>Quantification of ventricular endocardial cell numbers reveals normal numbers in rescued <italic>krit1<sup>ty219c</sup></italic> mutants by 48 hpf. At 55 hpf, ventricular endocardial cell numbers in <italic>krit1<sup>ty219c</sup></italic> mutants injected with mRNA encoding EGFP-Krit1 increase considerably compared to wild-type (WT). Mean values ± SEM are shown. ns: not significant, *p&lt;0.05, **p&lt;0.01.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig3-figsupp2-v2"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.010</object-id><label>Figure 3—figure supplement 3.</label><caption><title><italic>krit1</italic> expression decreases to a basal level by 96 hpf in rescued embryos.</title><p>Significant decrease of <italic>krit1</italic> levels from 24 to 48 hpf and from 48 to 96 hpf as determined by RT-qPCR. Mean values ± SEM are shown. ns: not significant, *p&lt;0.05, **p&lt;0.01.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig3-figsupp3-v2"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.011</object-id><label>Figure 3—figure supplement 4.</label><caption><title>Cadherin-5 is misexpressed in <italic>krit1<sup>ty219c</sup></italic> mutant embryonic hearts.</title><p>(<bold>A–C</bold>) Projections of confocal z-stack images of 96 hpf embryonic hearts marked by Cadherin 5 (Cdh5) staining. (<bold>A’–C’’’</bold>) Details are shown in single confocal plane sections of the atrioventricular canal (AVC) region (boxes) of superior cardiac valve leaflets of 96 hpf hearts marked by <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> expression (cyan), Cdh5 staining (yellow), and Alcam staining (magenta). (<bold>A’–A’’’</bold>) At 96 hpf, Alcam and Cdh5 expression is mainly restricted to luminal endocardial cells of the developing wild-type (WT) cardiac valve leaflet (asterisks). (<bold>B’–B’’’</bold>) <italic>krit1<sup>ty219c</sup></italic> mutants do not form valve leaflets and endocardial cells express Alcam and Cdh5 (asterisks). (<bold>C’–C’’’</bold>) Injection of <italic>egfp-krit1</italic> mRNA into <italic>krit1<sup>ty219c</sup></italic> mutants results in a dysmorphic cardiac valve leaflet at 96 hpf with an agglomeration of luminal leaflet cells marked by Alcam and Cdh5 expression (asterisks) (n = 17/23 <italic>krit1<sup>ty219c</sup></italic> mutants). A: atrium, V: ventricle, L: luminal, AL: abluminal. Scale bars are 50 μm (<bold>A–C</bold>) and 20 µm (<bold>A’–C’’’</bold>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig3-figsupp4-v2"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.012</object-id><label>Figure 3—figure supplement 5.</label><caption><title>Krit1 is required for abluminal cell fates during cardiac valve leafet formation.</title><p>(<bold>A</bold>) Details of a single confocal plane section of the atrioventricular canal (AVC) region of superior cardiac valve leaflet. A group of <italic>krit1<sup>ty219c</sup></italic> mutants injected with <italic>egfp-krit1</italic> mRNA showing a normal distribution of Alcam (magenta) positive luminal endocardial cells by 96 hpf (n = 6/23 <italic>krit1<sup>ty219c</sup></italic> mutants). A: atrium, V: ventricle, L: luminal, AL: abluminal. Scale bars are 10 µm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig3-figsupp5-v2"/></fig></fig-group><p>During the stage at which cardiac cushions form, we selected <italic>egfp-krit1</italic> mRNA injected <italic>krit1<sup>ty219c</sup></italic> mutant embryos with normal blood-flow and found that they had developed normal endocardial cushions by 48 hpf (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Next, we analyzed whether these rescued <italic>krit1<sup>ty219c</sup></italic> mutant embryos would revert to a mutant cardiovascular phenotype by 96 hpf, a point at which endocardial cushions have been transformed via complex cellular rearrangements into double-layered valve leaflets (<xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Pestel et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Scherz et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). In WT, those endocardial cells that face the luminal side of the valve leaflet and are exposed to the strongest shear stress, express high levels of <italic>klf2a</italic> (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) and can be identified by strong Alcam (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) and Cdh5 expression (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4A’–A’’’</xref>). In comparison, endocardial cells on the abluminal side of the valve leaflet have lower levels of <italic>klf2a</italic>, (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) and Alcam (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) and Cdh5 are only weakly expressed in abluminal cells (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4A’–A’’’</xref>). This is in tune with the more mesenchymal identity ascribed to this endocardial cell population (<xref ref-type="bibr" rid="bib35">Pestel et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). We found that <italic>krit1<sup>ty219c</sup></italic> mutant embryos with a cardiac rescue that were exposed to normal blood-flow at 48 hpf, developed strongly dysmorphic valve leaflets by 96 hpf (n = 17/23 <italic>krit1<sup>ty219c</sup></italic> mutant embryos). At that stage, most mutants had valve leaflet endocardial cells on the abluminal sides that strongly expressed high levels of Alcam similar to luminal <italic>klf2a</italic>-positive cells in WT (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; n = 17/23 <italic>krit1<sup>ty219c</sup></italic> mutant embryos). In addition, Cdh5 colocalized with Alcam on the abluminal side of dysmorphic valve leaflets (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4C’–C’’’</xref>). This phenotype corresponded with an agglomeration of endocardial cushion cells with characteristics of luminal cells. We ruled out that the observed phenotype resulted from an <italic>egfp-krit1</italic> overexpression effect because <italic>krit1</italic> mRNA levels in these rescued embryos had decreased to a basal level of expression by 96 hpf (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). In tune with this observation, untreated <italic>krit1<sup>ty219c</sup></italic> mutants express high levels of Cdh5 throughout the entire endocardium at 96 hpf (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B–B’’’</xref>) and Alcam is expressed at high levels within the AVC region (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B’–B’’’</xref>). Only few <italic>krit1<sup>ty219c</sup></italic> mutant embryos had a normal distribution of Alcam-positive luminal endocardial cells by 96 hpf, a phenotype more similar to WT (n = 6/23 <italic>krit1<sup>ty219c</sup></italic> mutant embryos; <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>). Taken together, the loss of Krit1 mostly resulted in a failure of endocardial cells to acquire mesenchymal-like fates and to generate an abluminal population of valve leaflet cells.</p></sec><sec id="s2-5"><title>Krit1 dampens <italic>klf2a</italic> expression and Notch activation during cardiac valve morphogenesis</title><p>Ingression of abluminal cells from cardiac cushions has been associated with a bias in <italic>klf2a</italic> expression levels: whereas some endocardial cushion cells express high levels of <italic>klf2a</italic> and contribute to the luminal part of the valve leaflet, others express lower levels of <italic>klf2a</italic> which correlates with a mesenchymal-like morphology and their contribution to the abluminal portion of the valve leaflet (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). Our findings suggest that elevated levels of <italic>klf2a</italic> mRNA are the cause for defects in valve leaflet morphogenesis. To assess <italic>klf2a</italic> expression in rescued <italic>krit1<sup>ty219c</sup></italic> mutant hearts, we used whole-mount <italic>in situ</italic> hybridization. By 54 hpf, <italic>klf2a</italic> was strongly expressed within cardiac cushions at the AVC, whereas in other regions of the endocardium expression levels were lower or undetectable (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). In <italic>krit1<sup>ty219c</sup></italic> mutants, <italic>klf2a</italic> was strongly expressed throughout the entire endocardium and was not restricted to the AVC (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). At 54 hpf, in <italic>krit1<sup>ty219c</sup></italic> mutant embryos that were rescued by injection of mRNA encoding EGFP-Krit1, the expression of <italic>klf2a</italic> had a normal pattern with a localized strong expression at the AVC cushions (n = 6/6) (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). However, by 96 hpf, the expression of <italic>klf2a</italic> was not restricted to the AVC and outflow tract regions of the endocardium as in WT (<xref ref-type="fig" rid="fig3">Figure 3J</xref>) but had reverted to wide and strong expressionpresent throughout the entire endocardium (n = 8/8) (<xref ref-type="fig" rid="fig3">Figure 3L</xref>).</p><p><italic>klf2a</italic> is a regulator of <italic>notch1b</italic> expression at cardiac cushions (<xref ref-type="bibr" rid="bib45">Vermot et al., 2009</xref>). In addition, several studies have demonstrated that the reduction of CCM protein levels is associated with decreased Notch activity in human endothelial cells (<xref ref-type="bibr" rid="bib49">Wüstehube et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">You et al., 2013</xref>). Hence, changes in Notch activity may contribute to defective cardiac valve leaflet morphogenesis in <italic>ccm</italic> mutants. To address this question, we first assessed <italic>notch1b</italic> expression by whole-mount <italic>in situ</italic> hybridization. At 48 hpf, <italic>notch1b</italic> was strongly expressed within high shear stress regions including the AVC of the WT heart (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). In contrast, <italic>notch1b</italic> was expressed throughout the entire endocardium in <italic>krit1<sup>ty219c</sup></italic> mutant embryos (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Next, we characterized Notch signaling activity using the <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> reporter. In WT, Notch activity was in a mosaic pattern within endocardial cushions and a few cushion cells neighboring the ventricle were consistently downregulating Notch activity (<xref ref-type="fig" rid="fig4">Figure 4C’</xref>; n &gt; 30 embryos analyzed). Those cells lacking Notch activity were in positions that have been shown to initiate endocardial sprouting behaviors and to contribute to formation of the abluminal portion of the cardiac valve leaflets (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). In striking contrast, in <italic>ccm2<sup>m201</sup></italic> and <italic>krit1<sup>ty219c</sup></italic> mutants, Notch reporter expression was expanded throughout large regions of the endocardium (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), and was especially active within all endocardial cells at the AVC region which demonstrated that a singling-out process and downregulation of Notch signaling among few cushions cells did not occur (<xref ref-type="fig" rid="fig4">Figure 4D’</xref>; n &gt; 30 embryos analyzed). In comparison, the expression of <italic>tbx2b</italic>, another AVC marker gene (<xref ref-type="bibr" rid="bib41">Sedletcaia and Evans, 2011</xref>), was not expanded in <italic>ccm2<sup>m201</sup></italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C–D</xref>). Hence, expansion of <italic>notch1b</italic> expression domain in <italic>ccm2<sup>m201</sup></italic> or <italic>krit1<sup>ty219c</sup></italic> mutants is not a result of regional expansion of the AVC. Taken together, our findings suggest a critical role for Krit1 in modulating expression levels of <italic>klf2a</italic> and for Notch signaling among endocardial cushion cells which may control endocardial sprouting during the formation of cardiac valve leaflets.</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.28939.013</object-id><label>Figure 4.</label><caption><title>Notch activity within endocardial cushion cells is affected in <italic>ccm</italic> mutants.</title><p>(<bold>A, B</bold>) Whole-mount <italic>in situ</italic> hybridization of <italic>notch1b</italic> cardiac expression at 48 hpf. (<bold>A</bold>) <italic>notch1b</italic> expression is restricted to endocardial cells of the atrioventricular canal (AVC) in wild-type (WT), while <italic>notch1b</italic> is strongly expressed throughout all ventricular cells in <italic>krit1<sup>ty219c</sup></italic> mutants (<bold>B</bold>). (<bold>C, D</bold>) Projections of single confocal z-section images of endocardial cells marked by <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> expression (yellow) and Alcam staining (magenta) at 54 hpf. (<bold>C</bold>) In WT, Notch activity is highest in endocardial cells of the AVC and outflow regions. (<bold>C’</bold>) Single confocal plane section of the AVC (white box in C) reveals that some endocardial cells close to the ventricle lack Notch activity (asterisks). (<bold>D</bold>) In <italic>ccm2<sup>m201</sup></italic> mutants, the domain of high Notch activity is expanded to most ventricular endocardial cells. (<bold>D’</bold>) Single confocal plane section of the AVC region (box in D, arrow) shows high Notch expression in all endocardial cells of the AVC region. A: atrium, V: ventricle, Scale bars are 50 μm (<bold>C, D</bold>), and 10 µm (<bold>C’, D’</bold>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.28939.014</object-id><label>Figure 4—figure supplement 1.</label><caption><title>The region of Notch activity within the endocardium is expanded in <italic>krit1<sup>ty219c</sup></italic> mutants.</title><p>(<bold>A, B</bold>) Projections of confocal z-stack images of embryonic hearts marked by <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> expression (yellow), Myh6 staining (cyan), and Actin staining (magenta) at 54 hpf. (<bold>A</bold>) In wild-type (WT), Notch activity is highest in endocardial cells of the atrioventricular canal (AVC) and outflow regions. (<bold>B</bold>) In <italic>krit1<sup>ty219c</sup></italic> mutants, the domain of high Notch activity is expanded to ventricular and atrial endocardial cells. (<bold>C, D</bold>) Whole-mount <italic>in situ</italic> hybridization of <italic>tbx2</italic> cardiac expression at 48 hpf. (<bold>A</bold>) <italic>Tbx2</italic> expression is restricted to the atrioventricular canal (AVC) both in wild-type (WT) and in <italic>ccm2<sup>m201</sup></italic> mutants (<bold>B</bold>). Arrowheads point at the AVC. A: atrium, V: ventricle, Scale bars are 50 μm (<bold>A, B</bold>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig4-figsupp1-v2"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study establishes CCM proteins as having an important role in endothelial mechanosensitive signaling. We report that levels of <italic>heg1</italic> mRNA expression are positively regulated by blood-flow in a Klf2-dependent manner and that Heg1 stabilizes Krit1 protein levels. We also show that overexpression of Heg1 and Krit1 dampens expression of <italic>klf2a</italic> mRNA. This establishes a negative feedback loop that desensitizes endothelial cells to blood-flow-induced mechanosensitive signaling by dampening expression levels of <italic>klf2a</italic>. The fine-tuning of blood-flow-sensitive responses is particularly important during developmental processes such as cardiac valvulogenesis, which involves establishment of regionalized differences in <italic>klf2a</italic> expression levels (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). While the endocardial cells facing the lumen of the heart experience high fluid shear forces, and consequently begin to express high levels of <italic>klf2a</italic>, those on the other side do not. In tune with this observation, the process of valvulogenesis is critically dependent on the biophysical stimulus by blood-flow (<xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>; <xref ref-type="bibr" rid="bib17">Heckel et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Pestel et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) and is affected by the loss of <italic>klf2a</italic> (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>). Hence, mechanosensitive signaling pathways actively reshape cardiac valve leaflets in a manner that is highly sensitive to constantly changing blood-flow conditions. The present work suggests that Krit1 plays an important role in modulating expression levels of <italic>klf2a</italic> during this complex morphogenetic process. Our results suggest that downregulation of endocardial mechanosensitivity by CCM proteins generates a bias in expression levels of <italic>klf2a</italic> which is critical for correct valvulogenesis.</p><p>In accordance with our findings, expression of the KRIT1-CCM2-associated protein CCM2L has also been reported in a blood-flow-dependent manner (<xref ref-type="bibr" rid="bib7">Cullere et al., 2015</xref>). In a complex with KRIT1 and CCM2, CCM2L directly binds to the MAP kinase MEKK3 and inhibits its activation. This reduces the ability of MEKK3 to phosphorylate MEK5 which is required to activate ERK5 (<xref ref-type="bibr" rid="bib7">Cullere et al., 2015</xref>). The MEKK3-MEK5-ERK5 pathway is involved in activation of <italic>KLF2</italic> expression (<xref ref-type="bibr" rid="bib55">Zhou et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Zhou et al., 2016</xref>), the control of endoMT (reviewed in <xref ref-type="bibr" rid="bib10">Drew et al., 2012</xref>), and murine cardiovascular development (<xref ref-type="bibr" rid="bib50">Yang et al., 2000</xref>; reviewed in <xref ref-type="bibr" rid="bib38">Rose et al., 2010</xref>). Activation of <italic>klf2a</italic> expression and control of endoMT processes could be particularly important during formation of functional cardiac valve leaflets. Within abluminal endocardial cells of the zebrafish cardiac valve leaflet, the loss of Krit1 prevents downregulation of Cdh5 and Alcam proteins, a function that might ultimately be related to elevated levels of Klf2a. As yet, no blood-flow-independent mechanism has been identified that would trigger such an upregulation of Klf2a in the absence of Ccm proteins (see model, <xref ref-type="fig" rid="fig5">Figure 5</xref>). As Klf2a regulates the expression of endocardial <italic>notch1b</italic> within endocardial cushions (<xref ref-type="bibr" rid="bib45">Vermot et al., 2009</xref>), the formation of abluminal valve leaflets may be regulated by a Notch-dependent lateral inhibition process similar to angiogenic sprouting of tip cells. Whereas high <italic>klf2a</italic> expression corresponds to expression of the endothelial junctional proteins Cdh5 and Alcam within luminal endocardial valve cells, abluminal endocardial cells that are shielded from blood-flow and express lower levels of <italic>klf2a</italic> and <italic>notch1b</italic> downregulate the expression of Cdh5 (<xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) and Alcam and acquire a more mesenchymal-like state. Several publications have discussed the possibility that downregulation of Cdh5 and Alcam in abluminal endocardial cells and the behaviour of these endocardial cells during zebrafish valvulogenesis (<xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>; <xref ref-type="bibr" rid="bib22">Lagendijk et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Scherz et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Steed et al., 2016</xref>) is highly reminiscent of the endoMT process that occurs during cardiac valve formation in the mouse (<xref ref-type="bibr" rid="bib6">Chiplunkar et al., 2013</xref>). Our findings now implicate CCM proteins in providing a bias in <italic>klf2a</italic> and <italic>notch1b</italic> expression levels within cardiac cushions, which may be further elaborated by Notch-dependent lateral inhibition that could allocate cells to an abluminal fate (see model, <xref ref-type="fig" rid="fig5">Figure 5</xref>). In tune with such a model, Notch activity was in a mosaic pattern within WT endocardial cushions, while in <italic>ccm</italic> mutants, Notch signaling was widely active. Interestingly, pharmacological inhibition of Notch signalling has been shown to cause similar cardiac valve leaflet morphogenesis defects (<xref ref-type="bibr" rid="bib2">Beis et al., 2005</xref>). Hence, it remains an important question for future research to elucidate whether Notch-dependent endocardial sprouting morphogenesis and/or endoMT are involved in the process of valve leaflet formation.</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.28939.015</object-id><label>Figure 5.</label><caption><title>Model of the molecular pathways involved in endocardial cushion cell sprouting at 54 hpf.</title><p>In wild-type, endocardial cells exposed to blood-flow have high levels of Klf2a, Notch, Alcam, and maintain cell adhesion. Ccm proteins provide a bias in Klf2a and Notch expression levels. Some cells that express lower levels of <italic>klf2a</italic> and have lower Notch activity establish protrusions and migrate into the cardiac jelly (endocardial sprouting). In <italic>ccm</italic> mutants, endocardial cells overexpress <italic>klf2a</italic> and have higher Notch activity because of a blood-flow-independent mechanism. As a consequence, high levels of Notch activity throughout the entire endocardium result in failure of endocardial sprouting.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-28939-fig5-v2"/></fig><p>Taken together, our findings uncover crucial roles of Heg1 and Krit1 in controlling the sensitivity of endothelial cells to hemodynamic forces. This may promote developmental adaptations in response to changes in the strength of hemodynamic forces that occur during cardiovascular development. Within the early zebrafish heart tube, shear forces resulting from blood-flow increase rapidly within the first 4–5 days post fertilization (<xref ref-type="bibr" rid="bib18">Hove et al., 2003</xref>). Similar changes in blood-flow dynamics also occur during the remodelling of the vasculature or during pathological changes of blood-flow patterns. It will be important to assess the physiological roles of CCM proteins during these different adaptations of the vasculature.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>gene (<italic>heg1</italic>)</td><td><italic>heg1</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-040714–1</td><td/></tr><tr><td>gene (<italic>krit1</italic>)</td><td><italic>krit1</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-030131–555</td><td/></tr><tr><td>gene (<italic>klf2a</italic>)</td><td><italic>klf2a</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-011109–1</td><td/></tr><tr><td>gene (<italic>klf2b</italic>)</td><td><italic>klf2b</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-011109–2</td><td/></tr><tr><td>gene (<italic>tnnt2a</italic>)</td><td><italic>tnnt2a</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-000626–1</td><td/></tr><tr><td>gene (<italic>ccm2</italic>)</td><td><italic>ccm2</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-040712–6</td><td/></tr><tr><td>gene (<italic>notch1b</italic>)</td><td><italic>notch1b</italic></td><td>ZFIN</td><td valign="bottom">ZFIN ID: ZDB-GENE-990415–183</td><td/></tr><tr><td>strain, strain background <break/>(<italic>krit1ty219c</italic>)</td><td><italic>krit1ty219c</italic></td><td valign="bottom">DOI:10.1242/dev.02469</td><td valign="bottom">ZFIN ID: ZDB-ALT-980203–1289</td><td/></tr><tr><td>strain, strain background <break/>(<italic>ccm2m201</italic>)</td><td><italic>ccm2m201</italic></td><td valign="bottom">PMID:9007227</td><td valign="bottom">ZFIN ID: ZDB-ALT-980203–523</td><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(EPV.Tp1-Mmu.Hbb:</italic> <break/><italic>Venus-Mmu.Odc1)s940</italic>)</td><td><italic>Tg(EPV.Tp1-Mmu.Hbb:</italic> <break/><italic>Venus-Mmu.Odc1)s940</italic></td><td valign="bottom">DOI:10.1242/dev.076000</td><td valign="bottom">ZFIN ID: ZDB-ALT-120419–6</td><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(kdrl:EGFP)s843</italic>)</td><td><italic>Tg(kdrl:EGFP)s843</italic></td><td valign="bottom">DOI:10.1242/dev.02087</td><td valign="bottom">ZFIN ID: ZDB-ALT-050916–14</td><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(fli1a:GAL4FF)ubs3</italic>)</td><td><italic>Tg(fli1a:GAL4FF)ubs3</italic></td><td valign="bottom">DOI:10.1016/j.cub. <break/>2011.10.016</td><td valign="bottom">ZFIN ID: ZDB-ALT-120113–6</td><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(hsp70l:Krit1_IRES_EGFP)md6</italic>)</td><td><italic>Tg(hsp70l:</italic> <break/><italic>Krit1_IRES_EGFP)md6</italic></td><td>this paper</td><td/><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(hsp70l:Ccm2_IRES_EGFP)md12</italic>)</td><td><italic>Tg(hsp70l:</italic> <break/><italic>Ccm2_IRES_EGFP)md12</italic></td><td>this paper</td><td/><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(hsp70l:Klf2a_IRES_EGFP)pbb22</italic>)</td><td><italic>Tg(hsp70l:</italic> <break/><italic>Klf2a_IRES_EGFP)pbb22</italic></td><td>this paper</td><td/><td/></tr><tr><td>strain, strain background <break/>(<italic>Tg(UAS:EGFP-Krit1,</italic> <break/><italic>cryaa:EGFP)pbb21</italic>)</td><td><italic>Tg(UAS:EGFP-Krit1,</italic> <break/><italic>cryaa:EGFP)pbb21</italic></td><td>this paper</td><td/><td/></tr><tr><td>genetic reagent <break/>(<italic>tnnt2a</italic> morpholino)</td><td><italic>tnnt2a</italic> MO</td><td valign="bottom">DOI:10.1038/ng875</td><td valign="bottom">ZFIN ID: ZDB-MRPHLNO-060317–4</td><td/></tr><tr><td>genetic reagent <break/>(<italic>klf2a</italic> morpholino)</td><td><italic>klf2a</italic> MO</td><td valign="bottom">DOI:10.1038/nature08889</td><td valign="bottom">ZFIN ID: ZDB-MRPHLNO-100610–9</td><td>2 ng/embryo</td></tr><tr><td>genetic reagent <break/>(<italic>klf2b</italic> morpholino)</td><td><italic>klf2b</italic> MO</td><td valign="bottom">DOI:10.1016/j.devcel. <break/>2014.12.016</td><td valign="bottom">ZFIN ID: ZDB-MRPHLNO-150427–1</td><td>1 ng/embryo</td></tr><tr><td>genetic reagent <break/>(<italic>heg1</italic> morpholino)</td><td><italic>heg1</italic> MO</td><td valign="bottom">PMID:14680629</td><td valign="bottom">ZFIN ID: ZDB-MRPHLNO-080714–5</td><td>5 ng/embryo</td></tr><tr><td>genetic reagent <break/>(<italic>klf2a</italic> probe)</td><td><italic>klf2a</italic></td><td valign="bottom">DOI:10.1016/j.devcel. <break/>2014.12.016</td><td valign="bottom">ZFIN ID: ZDB-FIG-150407–1</td><td>5 ng/embryo</td></tr><tr><td>genetic reagent <break/>(<italic>notch1b</italic> probe)</td><td><italic>notch1b</italic></td><td valign="bottom">DOI:10.1126/science. <break/>293.5535.1670</td><td valign="bottom">ZFIN ID: ZDB-FIG-151113–25</td><td/></tr><tr><td>genetic reagent <break/>(<italic>heg1</italic> probe)</td><td><italic>heg1</italic></td><td valign="bottom">DOI: 10.1242/dev.143362</td><td valign="bottom">ZFIN ID: ZDB-PUB-031217–1</td><td/></tr><tr><td>genetic reagent <break/>(<italic>tbx2</italic> probe)</td><td><italic>tbx2</italic></td><td valign="bottom">DOI: 10.1002/dvdy.22622</td><td valign="bottom">ZFIN ID: ZDB-PUB-110502–3</td><td/></tr><tr><td>Antibody (rabbit anti-VE- <break/>Cadherin (Cdh5))</td><td>Cdh5</td><td valign="bottom">DOI:10.1016/j.ydbio. <break/>2008.01.038</td><td valign="bottom">ZFIN ID: ZDB-PUB-080326–18</td><td>1:200</td></tr><tr><td>Antibody (mouse <break/>anti-Zn-8/Alcam)</td><td>Alcam</td><td valign="bottom">Developmental Studies <break/>Hybridoma Bank</td><td valign="bottom">ZFIN ID: ZDB-ATB-081002–22</td><td>1:25</td></tr><tr><td>Antibody (mouse anti-Myh6)</td><td>Myh6</td><td>Developmental Studies <break/>Hybridoma Bank</td><td valign="bottom">ZFIN ID: ZDB-ATB-081002–54</td><td>1:10</td></tr><tr><td>Antibody (Alexa Fluor <break/>633-conjugated <break/>goat anti-rabbit)</td><td>Alexa Fluor 633- <break/>conjugated goat anti-rabbit</td><td>Invitrogen A21070</td><td/><td>1:200</td></tr><tr><td>Antibody (Rhodamine <break/>Red- X-conjugated <break/>goat anti-mouse)</td><td>Rhodamine Red- X- <break/>conjugated goat <break/>anti-mouse</td><td>Jackson ImmunoResearch <break/>Laboratories 115-295-003</td><td/><td>1:200</td></tr><tr><td>Antibody (Dylight 649- <break/>conjugated goat anti-mouse)</td><td>Dylight 649- <break/>conjugated goat <break/>anti-mouse</td><td>Jackson ImmunoResearch <break/>Laboratories 115-495-003</td><td/><td>1:200</td></tr><tr><td>recombinant DNA reagent <break/>(pDestTol2 (#426))</td><td>pDestTol2</td><td>N. Lawson</td><td>Lawson Lab: #426</td><td/></tr><tr><td>recombinant DNA reagent <break/>(p5E-hsp70l (#222))</td><td>p5E-hsp70l</td><td>N. Lawson</td><td>Lawson Lab: #222</td><td/></tr><tr><td>recombinant DNA reagent <break/>(p5E-CMV/SP6 (#382))</td><td>p5E-CMV/SP6</td><td>Chien, Univ. Utah</td><td>Tol2kit: #382</td><td/></tr><tr><td>recombinant DNA reagent <break/>(p5E-UAS (#327))</td><td>p5E-UAS</td><td>Chien, Univ. Utah</td><td>Tol2kit: #327</td><td/></tr><tr><td>recombinant DNA reagent <break/>(p3E-IRES_EGFPpA (#389))</td><td>p3E-IRES_EGFPpA</td><td>N. Lawson</td><td>Lawson Lab: #389</td><td/></tr><tr><td>recombinant DNA reagent <break/>(p3E-cryaa:EGFPpA)</td><td>p3E-cryaa:EGFPpA</td><td>other</td><td/><td>plasmid was <break/>generated <break/>in our lab</td></tr><tr><td>recombinant DNA reagent <break/>(p3E-EGFPpA (#366))</td><td>p3E-EGFPpA</td><td>Chien, Univ. Utah</td><td>Tol2kit: #366</td><td/></tr><tr><td>recombinant DNA reagent <break/>(p3E-pA (#383))</td><td>p3E-pA</td><td>Chien, Univ. Utah</td><td>Tol2kit: #383</td><td/></tr><tr><td>recombinant DNA reagent <break/>(pDest_Tol2pA_Hsp70l: <break/>Krit1_IRES_EGFPpA)</td><td>pDest_Tol2pA_Hsp70l: <break/>Krit1_IRES_EGFPpA</td><td>this paper</td><td/><td/></tr><tr><td>recombinant DNA reagent <break/>(pDest_Tol2pA_Hsp70l: <break/>Ccm2_IRES_EGFPpA)</td><td>pDest_Tol2pA_Hsp70l: <break/>Ccm2_IRES_EGFPpA</td><td>this paper</td><td/><td/></tr><tr><td>recombinant DNA reagent <break/>(p3E-pA (pDest_Tol2pA_ <break/>Hsp70l:Klf2a_IRES_EGFPpA)</td><td>pDest_Tol2pA_Hsp70l: <break/>Klf2a_IRES_EGFPpA</td><td>this paper</td><td/><td/></tr><tr><td>recombinant DNA reagent <break/>(pDest_Tol2pA_UAS: <break/>EGFP-Krit1pA,cryaa:EGFPpA)</td><td>pDest_Tol2pA_UAS: <break/>EGFP-Krit1pA,cryaa:EGFPpA</td><td>this paper</td><td/><td/></tr><tr><td>recombinant DNA reagent <break/>(pDest_Tol2pA_CMV/SP6: <break/>EGFP-Krit1pA)</td><td>pDest_Tol2pA_CMV/SP6: <break/>EGFP-Krit1pA</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer heg1 FW)</td><td><italic>heg1</italic> FW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer heg1 RW)</td><td><italic>heg1</italic> RW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer krit1 FW)</td><td><italic>krit1</italic> FW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer krit1 RW)</td><td><italic>krit1</italic> RW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer klf2a FW)</td><td><italic>klf2a</italic> FW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer klf2a RW)</td><td><italic>klf2a</italic> RW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer eif1b FW)</td><td><italic>eif1b</italic> FW</td><td>this paper</td><td/><td/></tr><tr><td>sequence-based reagent <break/>(qPCR-primer eif1b RW)</td><td><italic>eif1b</italic> RW</td><td>this paper</td><td/><td/></tr><tr><td>commercial assay or kit <break/>(SP6 polymerase (mMessage <break/>Machine kit, Ambion))</td><td>SP6 polymerase</td><td>Ambion</td><td valign="bottom">Ambion:AM1340</td><td/></tr><tr><td>commercial assay or kit <break/>(RevertAid H Minus <break/>First Strand cDNA Synthesis kit <break/>(ThermoFisher Scientific))</td><td>RevertAid H Minus <break/>First Strand cDNA <break/>Synthesis kit</td><td>ThermoFisher Scientific</td><td valign="bottom">ThermoFisher Scientific:K1631</td><td/></tr><tr><td>commercial assay or kit <break/>(KAPA Sybr Fast qPCR kit (Peqlab))</td><td>KAPA Sybr Fast qPCR kit</td><td>Peglab</td><td valign="bottom">Peglab:4385612</td><td/></tr><tr><td>chemical compound, drug <break/>(1- phenyl-2-thiourea (PTU))</td><td>PTU</td><td>Sigma Aldrich</td><td valign="bottom">Sigma Aldrich:P7629</td><td>0.003%</td></tr><tr><td>chemical compound, drug <break/>(Rhodamine-Phalloidin)</td><td>Rhodamine-Phalloidin</td><td>Invitrogen</td><td>Invitrogen:R415</td><td>1:250</td></tr><tr><td>chemical compound, drug (Tricaine <break/>(3-amino benzoic acidethylester))</td><td>Tricaine</td><td>Sigma-Aldrich</td><td>Sigma Aldrich:A-5040</td><td>0.16 mg/ml</td></tr><tr><td>software, algorithm <break/>(GraphPad Prism6)</td><td>GraphPad Prism6</td><td>GraphPad</td><td/><td/></tr><tr><td>software, algorithm (Imaris <break/>(Bitplane, Version 8.1))</td><td>Imaris</td><td>Bitplane</td><td/><td/></tr><tr><td>software, algorithm (Fiji software)</td><td>Fiji</td><td valign="bottom">DOI:10.1038/nmeth.2019</td><td/><td/></tr><tr><td>software, algorithm <break/>(Adobe Bridge and Photoshop <break/>(Adobe Systems))</td><td>Adobe Bridge <break/>and Photoshop</td><td>Adobe</td><td/><td/></tr><tr><td>software, algorithm <break/>(Zen 8.1 Software (Zeiss))</td><td>Zen</td><td>Zeiss</td><td/><td/></tr><tr><td>software, algorithm <break/>(Excel 2010 (Microsoft Office))</td><td>Excel</td><td>Microsoft</td><td/><td/></tr><tr><td>software, algorithm <break/>(PikoReal software 2.2 <break/>(ThermoFisher Scientific))</td><td>PikoReal software</td><td>ThermoFisher Scientific</td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish genetics and maintenance</title><p>Handling of zebrafish was done in compliance with German and Brandenburg state law, carefully monitored by the local authority for animal protection (LUVG, Brandenburg, Germany; Animal protocol #2347-18-2015). The following strains of zebrafish were maintained under standard conditions as previously described (<xref ref-type="bibr" rid="bib47">Westerfield et al., 1997</xref>): <italic>krit1<sup>ty219c</sup></italic> (<xref ref-type="bibr" rid="bib26">Mably et al., 2006</xref>), <italic>ccm2<sup>m201</sup></italic> (<xref ref-type="bibr" rid="bib11">Driever et al., 1996</xref>), <italic>Tg(EPV.Tp1-Mmu.Hbb:Venus-Mmu.Odc1)<sup>s940</sup></italic> [here referred to as <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic>] (<xref ref-type="bibr" rid="bib32">Ninov et al., 2012</xref>), <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> (<xref ref-type="bibr" rid="bib19">Jin et al., 2005</xref>), <italic>Tg(fli1a:GAL4FF)<sup>ubs3</sup></italic> (Herwig et al., 2011). Some embryos were treated with 1-phenyl-2-thiourea (PTU) (Sigma Aldrich) prior to the appearance of pigmentation.</p></sec><sec id="s4-2"><title>Morpholino injections</title><p>The following morpholinos were used: <italic>tnnt2a</italic> (5’-CATGTTTGCTCTGATCTGACACGCA-3’) (2 ng/embryo) (<xref ref-type="bibr" rid="bib42">Sehnert et al., 2002</xref>), <italic>klf2a</italic> (5’-CTCGCCTATGAAAGAAGAGAGGATT-3’) (1 ng/embryo) (<xref ref-type="bibr" rid="bib31">Nicoli et al., 2010</xref>), <italic>klf2b</italic> (5’-AAAGGCAAGGTAAAGCCATGTCCAC-3’) (5 ng/embryo) (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>), <italic>heg1</italic> (5’-GTAATCGTACTTGCAGCAGGTGACA-3’) (5 ng/embryo) (<xref ref-type="bibr" rid="bib25">Mably et al., 2003</xref>).</p></sec><sec id="s4-3"><title>Molecular cloning</title><p>The open reading frames of zebrafish <italic>krit1</italic> (NM_001317001), <italic>klf2a</italic> (NM_131856), and <italic>ccm2</italic> (NM_001002315) were amplified by PCR and cloned into the Gateway pDONR221 vector (referred to as pME-<italic>krit1</italic>, pME-<italic>klf2a</italic>, and pME-<italic>ccm2</italic>, respectively). To generate the <italic>krit1</italic> fusion plasmids, <italic>EGFP</italic> was fused in the N-terminal site of <italic>krit1</italic> (pME-<italic>EGFP-krit1</italic>).</p><p>These middle entry constructs were used in combination with the following Gateway plasmids to generate final constructs by standard Gateway cloning recombination reactions: pDestTol2 (#426, obtained from N. Lawson), p5E-<italic>hsp70l</italic> (#222, obtained from N. Lawson), p5E-<italic>CMV/SP6</italic> (#382, obtained from Chien, Univ. Utah), p5E-<italic>UAS</italic> (#327, obtained from Chien, Univ. Utah), p3E-<italic>IRES_EGFPpA</italic> (#389, obtained from N. Lawson), p3E-<italic>cryaa:EGFPpA</italic>, p3E-<italic>EGFPpA</italic> (#366, obtained from Chien, Univ. Utah), p3E-<italic>pA</italic> (#383, obtained from Chien, Univ. Utah).</p><p>Final plasmids:</p><p>pDest_Tol2pA_<italic>Hsp70l:Krit1_IRES_EGFPpA,</italic></p><p>pDest_Tol2pA<italic>_Hsp70l:Ccm2_IRES_EGFPpA</italic>,</p><p>pDest_Tol2pA_<italic>Hsp70l:Klf2a_IRES_EGFPpA</italic>,</p><p>pDest_Tol2pA<italic>_UAS:EGFP-Krit1pA,cryaa:EGFPpA</italic>,</p><p>pDest_Tol2pA_<italic>CMV/SP6:EGFP-Krit1pA</italic>.</p></sec><sec id="s4-4"><title>Generation of transgenic lines of zebrafish</title><p>Transformation plasmids (25 pg/embryo) were co-injected together with mRNA encoding Tol2 transposase (50 pg/embryo) into one-cell-stage zebrafish embryos. Several independent transgenic lines were established for each construct. In functional tests and localization studies, these independent lines resulted in comparable phenotypes. One transgene for each construct was selected for further analyses:</p><p>Tg(hsp70l:Krit1_IRES_EGFP)<sup>md6</sup></p><p>Tg(hsp70l:Ccm2_IRES_EGFP)<sup>md12</sup></p><p>Tg(hsp70l:Klf2a_IRES_EGFP)<sup>pbb22</sup></p><p><italic>Tg(UAS:EGFP-Krit1,cryaa:EGFP)<sup>pbb21</sup></italic> [here referred to as <italic>Tg(UAS:EGFP-Krit1)<sup>pbb21</sup></italic>]</p></sec><sec id="s4-5"><title>Heat-shock experiments</title><p>To assess levels of <italic>klf2a</italic> mRNA following <italic>krit1</italic> overexpression, <italic>Tg(hsp70l:Krit1_IRES_EGFP)<sup>md6</sup></italic> was crossed to wild-type and the resulting embryos were heat-shocked at 14 hpf (30 min at 37°C), at 24 hpf (40 min at 38°C), and at 40 hpf (45 min at 38°C). Alternatively, for the experiment shown in <xref ref-type="fig" rid="fig2">Figure 2C,D</xref>, embryos obtained from <italic>Tg(hsp70l:Krit1_IRES_EGFP)<sup>md6</sup></italic> or <italic>Tg</italic>(<italic>hsp70l:Ccm2_IRES_EGFP</italic>)<italic><sup>md12</sup></italic> crossed to <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> were additionally heat-shocked at 48 hpf (45 min at 38°C). For the experiment shown in <xref ref-type="fig" rid="fig1">Figure 1B</xref>, <italic>Tg(hsp70l:Klf2a_IRES_EGFP)<sup>pbb22</sup></italic> were crossed to wild-type and the resulting embryos were heat-shocked at 48 hpf (45 min at 38°C).</p></sec><sec id="s4-6"><title>mRNA injection experiments</title><p>Capped mRNA encoding EGFP-Krit1 or Heg1 was synthesized using SP6 polymerase (mMessage Machine kit, Ambion). For rescue experiments, 150 pg of <italic>egfp-krit1</italic> mRNA was injected into one-cell-stage zebrafish embryos. Embryos were selected for EGFP fluorescence at 6 hpf and the genotype was assessed by sequencing. For <italic>heg1</italic> overexpression, 100 pg of <italic>heg1</italic> mRNA was injected into one-cell-stage zebrafish embryos.</p></sec><sec id="s4-7"><title>Statistical analysis of the efficiency of mRNA rescue experiments</title><p>Statistical analysis of the efficiency of <italic>egfp-krit1</italic> mRNA rescue experiments (as shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) was done using GraphPad Prism6 (Student’s t-test, p=0.008 and p=0.005, respectively).</p><p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th>Unpaired t-test</th><th>Mean diff.</th><th>Summary</th><th>Individual P value</th></tr></thead><tbody><tr><td rowspan="3">48 hpf <italic>egfp-krit1</italic> <break/>mRNA</td><td valign="bottom">WT vs. <italic>krit1</italic></td><td valign="bottom">100.0</td><td valign="bottom">****</td><td valign="bottom">&lt;0.0001</td></tr><tr><td valign="bottom">WT vs. WT + <italic>egfp-krit1</italic> mRNA</td><td valign="bottom">0.0</td><td valign="bottom">ns</td><td valign="bottom">&gt;0.9999</td></tr><tr><td valign="bottom">WT vs. <italic>krit1 + egfp-krit1</italic> mRNA</td><td valign="bottom">28</td><td valign="bottom">***</td><td valign="bottom">0.0004</td></tr></tbody></table></table-wrap></p><p>Statistical analysis of the rescue efficiency of <italic>egfp-krit1</italic> mRNA injection into <italic>krit1<sup>ty219c</sup></italic> mutant embryos was based on the presence of blood-flow at 48 hpf for all embryos, and at 96 hpf for those embryos that had blood-flow at 48hpf. The percentages of embryos with blood-flow was recorded for three individual experiments and compared with GraphPad Prism6, using a 2way ANOVA with Multiple comparisons without correction.</p><p><table-wrap id="inlinetable2" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>48 hpf</th><th valign="top">Number of WT <break/>with blood-flow/total</th><th valign="top">Number of <italic>krit1<sup>ty219c</sup></italic> <break/>with blood-flow/total</th><th valign="top">Number of<break/>WT + <italic>egfp-krit1</italic> <break/>mRNA with blood-<break/>flow/total</th><th valign="top">Number of<break/><italic>krit1<sup>ty219c</sup> + egfp-<break/>krit1 mRNA with <break/>blood-flow/total</italic></th></tr></thead><tbody><tr><td>1</td><td>5/5</td><td>0/3</td><td>32/32</td><td>15/15</td></tr><tr><td>2</td><td>78/78</td><td>0/17</td><td>40/40</td><td>42/42</td></tr><tr><td>3</td><td>69/69</td><td>0/26</td><td>21/21</td><td>11/11</td></tr></tbody></table></table-wrap></p><p><table-wrap id="inlinetable3" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>96 hpf</th><th valign="top">Number of WT <break/>with blood-flow <break/>at 48 hpf and 96 <break/>hpf/total</th><th valign="top">Number of <italic>krit1<sup>ty219c</sup></italic> <break/>with blood-flow at 48 <break/>hpf and 96 hpf/total</th><th valign="top">Number of WT + <italic>egfp-</italic> <break/><italic>krit1</italic> mRNA with<break/>blood-flow <break/>at 48 hpf and 96 <break/>hpf/total</th><th valign="top">Number of<break/><italic>krit1<sup>ty219c</sup> + egfp-<break/>krit1</italic> mRNA <break/>with blood-flow<break/>at 48 hpf and 96<break/>hpf/total</th></tr></thead><tbody><tr><td valign="top">1</td><td valign="top">67/67</td><td valign="top">0/28</td><td valign="top">59/59</td><td valign="top">5/22</td></tr><tr><td valign="top">2</td><td valign="top">70/70</td><td valign="top">0/11</td><td valign="top">20/21</td><td valign="top">1/11</td></tr><tr><td valign="top">3</td><td valign="top">57/57</td><td valign="top">0/13</td><td valign="top">30/30</td><td valign="top">7/18</td></tr></tbody></table></table-wrap></p><p><table-wrap id="inlinetable4" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="4">Within each row, compare columns (simple effects within rows)</th></tr><tr><th>Uncorrected Fisher's LSD</th><th>Mean diff.</th><th>Summary</th><th>Individual P value</th></tr></thead><tbody><tr><td rowspan="3">48 hpf</td><td valign="bottom">WT vs. <italic>krit1</italic></td><td valign="bottom">100.0</td><td valign="bottom">****</td><td valign="bottom">&lt;0.0001</td></tr><tr><td valign="bottom">WT vs. WT + <italic>egfp-krit1</italic> mRNA</td><td valign="bottom">0.0</td><td valign="bottom">ns</td><td valign="bottom">&gt;0.9999</td></tr><tr><td valign="bottom">WT vs. <italic>krit1 + egfp-krit1</italic> mRNA</td><td valign="bottom">0.0</td><td valign="bottom">ns</td><td valign="bottom">&gt;0.9999</td></tr><tr><td rowspan="3">96 hpf</td><td valign="bottom">WT vs. <italic>krit1</italic></td><td valign="bottom">100.0</td><td valign="bottom">****</td><td valign="bottom">&lt;0.0001</td></tr><tr><td valign="bottom">WT vs. WT + <italic>egfp-krit1</italic> mRNA</td><td valign="bottom">1.590</td><td valign="bottom">ns</td><td valign="bottom">0.7212</td></tr><tr><td valign="bottom">WT vs. <italic>krit1 + egfp-krit1</italic> mRNA</td><td valign="bottom">76.44</td><td valign="bottom">****</td><td valign="bottom">&lt;0.0001</td></tr></tbody></table></table-wrap></p></sec><sec id="s4-8"><title>Quantifications of ventricular endocardial cell numbers</title><p>Endocardial cell numbers of the ventricles at 48 hpf and 55 hpf of WT and <italic>krit1<sup>ty219c</sup></italic> mutants were quantified as previously shown (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). Nuclei were visualized by <italic>Tg(kdrl:GFP)<sup>s843</sup></italic> expression and were counted within the ventricle (for endocardium). Cell numbers are shown as means with SEM. Prism 6 (GraphPad) was used to perform an unpaired t-test (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Means are significantly different when p&lt;0.05.</p><p><table-wrap id="inlinetable5" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td rowspan="3">48 hpf</td><td/><td>n</td><td>Average cell number</td><td valign="top">SEM</td><td>p-value</td></tr><tr><td>WT</td><td>6</td><td>68</td><td valign="top">±2.362</td><td rowspan="2">0.5723</td></tr><tr><td><italic>krit1 + egfp-krit1</italic> mRNA</td><td>6</td><td>65</td><td valign="top">±3.572</td></tr></tbody></table></table-wrap></p><p><table-wrap id="inlinetable6" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td rowspan="3">55 hpf</td><td/><td>n</td><td>Average cell number</td><td valign="top">SEM</td><td>p-value</td></tr><tr><td>WT</td><td>3</td><td>78</td><td valign="top">±2.028</td><td rowspan="2">0.0093</td></tr><tr><td><italic>krit1 + egfp-krit1</italic> mRNA</td><td>3</td><td>112</td><td valign="top">±7.024</td></tr></tbody></table></table-wrap></p></sec><sec id="s4-9"><title>Whole-mount immunohistochemistry and <italic>in situ</italic> hybridization</title><p>Zebrafish whole-mount immunohistochemistry was performed on 30 hpf, 48 hpf, 54 hpf, and 96 hpf embryos as previously described (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). The following antibodies were used: rabbit anti-VE-Cadherin (Cdh5) (1:200, a kind donation from Markus Affolter, Basel) (<xref ref-type="bibr" rid="bib3">Blum et al., 2008</xref>), mouse anti-Zn-8/Alcam (1:25, Developmental Studies Hybridoma Bank), and mouse anti-Myh6 (1:10, Developmental Studies Hybridoma Bank, S46). Secondary antibodies were Alexa Fluor 633-conjugated goat anti-rabbit (1:200, Invitrogen A21070), Rhodamine Red-X-conjugated goat anti-mouse (1:200, Jackson ImmunoResearch Laboratories 115-295-003), and Dylight 649-conjugated goat anti-mouse (1:200, Jackson ImmunoResearch Laboratories 115-495-003). Rhodamine-Phalloidin (1:250, Invitrogen R415) was incubated together with secondary antibodies. For Cdh5 antibody staining, embryos were fixed with 2% PFA overnight and permeabilized with PBST with 0.5% Triton X-100 for 1 hr and subsequently incubated with primary antibody diluted in PBST with 0.2% Triton X-100, 1% BSA, and 5% NGS. All specimens were mounted in SlowFade Gold (Invitrogen S36936). Images were recorded on LSM 710, or LSM 780 confocal microscopes (Zeiss) and processed with Imaris (Bitplane, Version 8.1) or Fiji software (<xref ref-type="bibr" rid="bib40">Schindelin et al., 2012</xref>).</p><p>Whole-mount <italic>in situ</italic> hybridization experiments were performed as previously described (<xref ref-type="bibr" rid="bib20">Jowett and Lettice, 1994</xref>). For all experiments embryos were fixed overnight with 4% PFA. For <xref ref-type="fig" rid="fig3">Figures 3G–L</xref>, 54 hpf and 96 hpf embryos were stained with a <italic>klf2a</italic> probe previously published (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). For <xref ref-type="fig" rid="fig4">Figures 4A–B</xref>, 48 hpf embryos were stained with a <italic>notch1b</italic> probe previously published (<xref ref-type="bibr" rid="bib46">Walsh and Stainier, 2001</xref>) (the plasmid was a kind gift from Didier Stainier). For <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref>, 30 hpf and 48 hpf embryos were stained with a <italic>heg1</italic> probe previously published (<xref ref-type="bibr" rid="bib30">Münch et al., 2017</xref>). For <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1C–D</xref>, 48 hpf embryos were stained with a <italic>tbx2b</italic> probe (<xref ref-type="bibr" rid="bib41">Sedletcaia and Evans, 2011</xref>). Images were recorded with 10x or 20x objectives on an Axioskop (Zeiss) with an EOS 5 D Mark III (Canon) camera, and processed using Adobe Bridge and Photoshop (Adobe Systems).</p></sec><sec id="s4-10"><title>Live imaging</title><p>Embryos were dechorionated manually and embedded in 1% low melting agarose (Lonza 50081) containing 0.16 mg/ml Tricaine (3-amino benzoic acidethylester, Sigma-Aldrich A-5040). Images were recorded with a LSM 710 confocal microscope (Zeiss) at 10x.</p></sec><sec id="s4-11"><title>Ratiometric corrected total tissue fluorescence (CTTF) image analysis</title><p>The ratiometric measurements of <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> fluorescence in atrium versus ventricle and AVC of the embryonic heart (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) was done as previously described (<xref ref-type="bibr" rid="bib29">McCloy et al., 2014</xref>). As overexpression of <italic>krit1</italic> also resulted in an upregulation of EGFP, the overlap of EGFP with <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> fluorescence was safely separated into two different channels by recording the images using the online fingerprinting function of the Zen 8.1 Software (Zeiss). Images were acquired maintaining fixed recording settings. From a 3D confocal image, the z-portion corresponding to the entire heart was selected. Regions of single z-planes corresponding to atrium or to ventricle plus the AVC were selected and fluorescence was measured until entire hearts were covered. The corrected total tissue fluorescence [CTTF = integrated density – (area of selected tissue x mean fluorescence of background readings)] was calculated using Excel 2010 (Microsoft Office). Next, all CTTF values collected for atrium as well as for ventricle plus AVC of each heart were averaged. The mean of atrium CTTF values was divided by the mean of ventricle plus AVC CTTF values. A mean value of 1 corresponds to an equal expression of <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> in both heart chambers. All measurements and tissue selection were performed using Fiji software (<xref ref-type="bibr" rid="bib40">Schindelin et al., 2012</xref>). Statistical analysis was done with Excel 2010 (Microsoft Office) using an unpaired t-test (n: number of hearts analyzed, <italic>hs</italic>: heat-shock, *p&lt;0.05, **p&lt;0.01).</p><p><table-wrap id="inlinetable7" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top">n</th><th>Ratio <italic>TP1:</italic>VenusPEST <break/>Atrium/Ventricle (CTTF)</th><th>SEM</th><th>p</th></tr></thead><tbody><tr><td>WT</td><td valign="top">19</td><td>0.213</td><td>±0.024</td><td rowspan="2">0.0005</td></tr><tr><td><italic>hs:</italic>Krit1</td><td valign="top">18</td><td>0.418</td><td>±0.048</td></tr></tbody></table></table-wrap></p><p><table-wrap id="inlinetable8" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top">n</th><th>Ratio <italic>TP1:</italic>VenusPEST <break/>Atrium/Ventricle (CTTF)</th><th>SEM</th><th>p</th></tr></thead><tbody><tr><td>WT</td><td valign="top">19</td><td>0.290</td><td>±0.040</td><td rowspan="2">0.0261</td></tr><tr><td><italic>hs:</italic>Ccm2</td><td valign="top">20</td><td>0.428</td><td>±0.044</td></tr></tbody></table></table-wrap></p><p>To quantify the fluorescent levels of <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> in the AVC of WT (heat-shock control) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), <italic>hs:</italic>Krit1 and <italic>hs:</italic>Ccm2, a section of 20 µm corresponding to the entire AVC was selected from a maximum projection of confocal z-stacks of the AVC. The CTTF value of each AVC was measured and all the values were divided by the average CTTF of the controls for normalization.</p><p><table-wrap id="inlinetable9" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top">n</th><th>CTTF mean</th><th>SEM</th><th>p</th></tr></thead><tbody><tr><td>WT</td><td valign="top">19</td><td>1.000</td><td>±0.121</td><td rowspan="2">0.0426</td></tr><tr><td><italic>hs:</italic>Krit1</td><td valign="top">19</td><td>0.671</td><td>±0.099</td></tr></tbody></table></table-wrap></p><p><table-wrap id="inlinetable10" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top">n</th><th>CTTF mean</th><th>SEM</th><th>p</th></tr></thead><tbody><tr><td>WT</td><td valign="top">19</td><td>1.000</td><td>±0.059</td><td rowspan="2">0.0481</td></tr><tr><td><italic>hs:</italic>Ccm2</td><td valign="top">20</td><td>0.798</td><td>±0.078</td></tr></tbody></table></table-wrap></p><p>To quantify the fluorescent levels of EGFP-Krit1 in WT and <italic>heg1</italic> morphants, maximum projections of confocal z-stacks of manually extracted 30 hpf hearts (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>) or of the caudal plexus region (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>) were used. The background intensity was measured in five different areas of each image. To measure the caudal plexus region, an area between two intersegmental vessels from the most dorsal to the most ventral side of the caudal plexus was selected. This was repeated in three different areas for each embryo. All measurements and tissue selection were performed using Fiji software (<xref ref-type="bibr" rid="bib40">Schindelin et al., 2012</xref>). The CTTF was calculated using Excel 2010 (Microsoft Office). All the values were divided by the average intensity of the controls.</p><p><table-wrap id="inlinetable11" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top">n</th><th>CTTF mean hearts</th><th>SEM</th><th>P</th></tr></thead><tbody><tr><td>EGFP-Krit1 levels WT</td><td valign="top">5</td><td>1.000</td><td>±0.074</td><td rowspan="2">≤0.0005</td></tr><tr><td>EGFP-Krit1 levels <italic>heg1</italic> MO</td><td valign="top">10</td><td>0.600</td><td>±0.049</td></tr></tbody></table></table-wrap></p><p><table-wrap id="inlinetable12" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top">n</th><th>CTTF mean caudal plexus region</th><th>SEM</th><th>p</th></tr></thead><tbody><tr><td>EGFP-Krit1 levels WT</td><td valign="top">5</td><td>1.000</td><td>±0.081</td><td rowspan="2">&lt;0.0001</td></tr><tr><td>EGFP-Krit1 levels <italic>heg1</italic> MO</td><td valign="top">5</td><td>0.305</td><td>±0.059</td></tr></tbody></table></table-wrap></p></sec><sec id="s4-12"><title>Quantifications of mRNA expression by RT-qPCR</title><p>For RT-qPCR experiments, 25 zebrafish embryos were pooled for each condition (three biological replicates). For heat-shock conditions, controls of each biological replicate were composed of heat-shocked siblings from the same clutch lacking EGFP expression. Total RNA was extracted with Trizol (Sigma) and Phase Lock Gel Heavy tubes (1.5 mL, Prime 5) and the corresponding cDNA was synthesized from total RNA with the RevertAid H Minus First Strand cDNA Synthesis kit (ThermoFisher Scientific). RT-qPCR experiments were performed as described (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>) using 18 ng cDNA per technical replicate and the KAPA Sybr Fast qPCR kit (Peqlab) on a PikoReal 96 Real-Time PCR System (ThermoFisher Scientific). Cycle threshold (Ct) values were determined by PikoReal software 2.2 (ThermoFisher Scientific). <italic>eif1b</italic> was used as a housekeeping gene.</p><p>The following primers were used for qRT-PCR:</p><p><table-wrap id="inlinetable13" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Target</th><th>Sequence 5’−3’</th></tr></thead><tbody><tr><td valign="top"><italic>heg1</italic></td><td valign="top">Fw _ GCTCTTATTGTCACCTGCTGC <break/>Rv _ CGGATAGATGCAGGAATGCC</td></tr><tr><td valign="top"><italic>krit1</italic></td><td valign="top">Fw _ GTCTGAGCACTAGTGAGGGTG <break/>Rv _ GACCTGTCCTGTGAAAAACGC</td></tr><tr><td valign="top"><italic>klf2a</italic></td><td valign="top">Fw _ CTGGGAGAACAGGTGGAAGGA <break/>Rv _ CCAGTATAAACTCCAGATCCAGG</td></tr><tr><td valign="top"><italic>eif1b</italic></td><td valign="top">Fw _ CAGAACCTCCAGTCCTTTGATC <break/>Rv _ GCAGGCAAATTTCTTTTTGAAGGC</td></tr></tbody></table></table-wrap></p><p>Results were analyzed using the comparative threshold cycle method (2–ΔΔCt) to compare gene expression levels between samples as previously described (<xref ref-type="bibr" rid="bib24">Livak and Schmittgen, 2001</xref>). As an internal reference, we used zebrafish <italic>eif1b</italic> (<xref ref-type="bibr" rid="bib36">Renz et al., 2015</xref>). Control sample values were normalized to 1. In the table below, the mean of the fold changes and the corresponding SEM of each biological replicate after normalization is shown. As each single biological replicate represents an independent experiment from an independent clutch of embryos, ratio paired t-tests were done with Prism 6 (GraphPad) (Stg: developmental stage of zebrafish embryos at RNA extraction, n: number of independent biological replicates analyzed, *p&lt;0.05, **p&lt;0.01, <italic>hs</italic>: heat-shock, mean &gt;1 corresponds with target upregulation; mean &lt;1 represents target downregulation).</p><p><table-wrap id="inlinetable14" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Treatment</th><th rowspan="2">Stg (hpf)</th><th rowspan="2">n</th><th colspan="3"><italic>heg1</italic></th><th colspan="3"><italic>krit1</italic></th><th colspan="3"><italic>klf2a</italic></th></tr><tr><th>Mean</th><th>SEM</th><th>p</th><th>Mean</th><th>SEM</th><th>p</th><th>Mean</th><th>SEM</th><th>p</th></tr></thead><tbody><tr><td><italic>tnnt2a</italic> MO</td><td valign="top">54</td><td>3</td><td>0.85</td><td>0.008</td><td>0.013</td><td>1.06</td><td>0.009</td><td>0.103</td><td>-</td><td>-</td><td>-</td></tr><tr><td><italic>klf2a/b</italic> MO</td><td valign="top">54</td><td>4</td><td>0.77</td><td>0.034</td><td>0.045</td><td>1.17</td><td>0.029</td><td>0.103</td><td>-</td><td>-</td><td>-</td></tr><tr><td valign="top"><italic>hs:</italic>Klf2a</td><td valign="top">54</td><td valign="top">3</td><td valign="top">2.56</td><td valign="top">0.089</td><td valign="top">0.044</td><td valign="top">1.38</td><td valign="top">0.061</td><td valign="top">0.151</td><td valign="top">-</td><td valign="top">-</td><td valign="top">-</td></tr><tr><td><italic>hs:</italic>Krit1</td><td valign="top">48</td><td>4</td><td>-</td><td>-</td><td>-</td><td>9.77</td><td>0.063</td><td>0.001</td><td>0.63</td><td>0.059</td><td>0.044</td></tr><tr><td><italic>heg1</italic> mRNA</td><td valign="top">24</td><td>3</td><td>4.01</td><td>0.059</td><td>0.0095</td><td>-</td><td>-</td><td>-</td><td>0.31</td><td>0.107</td><td>0.04</td></tr><tr><td><italic>heg1</italic> mRNA</td><td valign="top">48</td><td>3</td><td>2.47</td><td>0.036</td><td>0.0082</td><td>-</td><td>-</td><td>-</td><td>0.68</td><td>0.023</td><td>0.019</td></tr><tr><td><italic>egfp-krit1</italic> mRNA</td><td valign="top">24</td><td>3</td><td>-</td><td>-</td><td>-</td><td>7.06</td><td>0.125</td><td>0.021</td><td>-</td><td>-</td><td>-</td></tr><tr><td><italic>egfp-krit1</italic> mRNA</td><td valign="top">48</td><td>3</td><td>-</td><td>-</td><td>-</td><td>3.24</td><td>0.053</td><td>0.011</td><td>-</td><td>-</td><td>-</td></tr><tr><td><italic>egfp-krit1</italic> mRNA</td><td valign="top">96</td><td>3</td><td>-</td><td>-</td><td>-</td><td>1.20</td><td>0.161</td><td>0.675</td><td>-</td><td>-</td><td>-</td></tr></tbody></table></table-wrap></p><p>To prove that differences in average values of <italic>krit1</italic> mRNA levels between 24 hpf and 48 hpf, 48 hpf and 96 hpf, 24 hpf and 96 hpf were significant, a ratio paired t-test was performed, as in each single biological replicate, embryos of 24, 48, and 96 hpf were from the same clutches. The mean of the ratio indicated in the table below is always between 1 and 0, and this accounts for target downregulation.</p><p><table-wrap id="inlinetable15" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Compared stages <break/>(hpf)</th><th valign="top">Mean of the ratio</th><th valign="top">SEM</th><th valign="top">p</th></tr></thead><tbody><tr><td valign="top">24–48</td><td valign="top">0.4594</td><td valign="top">±0.082</td><td valign="top">0.027</td></tr><tr><td valign="top">48–96</td><td valign="top">0.3691</td><td valign="top">±0.110</td><td valign="top">0.029</td></tr><tr><td valign="top">24–96</td><td valign="top">0.1696</td><td valign="top">±0107</td><td valign="top">0.009</td></tr></tbody></table></table-wrap></p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank M Affolter and H Belting (Basel), and D Stainier (Bad Nauheim) for reagents or fish lines. Thanks to A Michels for contributing some of the RT-qPCR data. Thanks also to O Baumann, A Hubig, M Kneiseler, A Kühnel, and B Wuntke for technical support. For critical reading and discussions of the project and the manuscript we are indebted to C Albiges-Rizo, E Faurobert, R Hodge, and team members. The group has been generously supported by the excellence cluster REBIRTH, SFB958, and by Deutsche Forschungsgemeinschaft (DFG) projects SE2016/7-2 and SE2016/10-1 to SA-S.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Handling of zebrafish was done in compliance with German and Brandenburg State law, carefully monitored by the local authority for animal protection (LUGV, Brandenburg, Germany; Animal protocol#2347-18-2015 ).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.28939.016</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-28939-transrepform-v2.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeyens</surname> <given-names>N</given-names></name><name><surname>Schwartz</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Biomechanics of vascular mechanosensation and remodeling</article-title><source>Molecular Biology of the Cell</source><volume>27</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1091/mbc.E14-11-1522</pub-id><pub-id pub-id-type="pmid">26715421</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beis</surname> <given-names>D</given-names></name><name><surname>Bartman</surname> <given-names>T</given-names></name><name><surname>Jin</surname> <given-names>SW</given-names></name><name><surname>Scott</surname> <given-names>IC</given-names></name><name><surname>D'Amico</surname> <given-names>LA</given-names></name><name><surname>Ober</surname> <given-names>EA</given-names></name><name><surname>Verkade</surname> <given-names>H</given-names></name><name><surname>Frantsve</surname> <given-names>J</given-names></name><name><surname>Field</surname> <given-names>HA</given-names></name><name><surname>Wehman</surname> <given-names>A</given-names></name><name><surname>Baier</surname> <given-names>H</given-names></name><name><surname>Tallafuss</surname> <given-names>A</given-names></name><name><surname>Bally-Cuif</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Jungblut</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development</article-title><source>Development</source><volume>132</volume><fpage>4193</fpage><lpage>4204</lpage><pub-id pub-id-type="doi">10.1242/dev.01970</pub-id><pub-id pub-id-type="pmid">16107477</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname> <given-names>Y</given-names></name><name><surname>Belting</surname> <given-names>HG</given-names></name><name><surname>Ellertsdottir</surname> <given-names>E</given-names></name><name><surname>Herwig</surname> <given-names>L</given-names></name><name><surname>Lüders</surname> <given-names>F</given-names></name><name><surname>Affolter</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo</article-title><source>Developmental Biology</source><volume>316</volume><fpage>312</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.01.038</pub-id><pub-id pub-id-type="pmid">18342303</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulday</surname> <given-names>G</given-names></name><name><surname>Rudini</surname> <given-names>N</given-names></name><name><surname>Maddaluno</surname> <given-names>L</given-names></name><name><surname>Blécon</surname> <given-names>A</given-names></name><name><surname>Arnould</surname> <given-names>M</given-names></name><name><surname>Gaudric</surname> <given-names>A</given-names></name><name><surname>Chapon</surname> <given-names>F</given-names></name><name><surname>Adams</surname> <given-names>RH</given-names></name><name><surname>Dejana</surname> <given-names>E</given-names></name><name><surname>Tournier-Lasserve</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice</article-title><source>The Journal of Experimental Medicine</source><volume>208</volume><fpage>1835</fpage><lpage>1847</lpage><pub-id pub-id-type="doi">10.1084/jem.20110571</pub-id><pub-id pub-id-type="pmid">21859843</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>AC</given-names></name><name><surname>Drakos</surname> <given-names>SG</given-names></name><name><surname>Ruiz</surname> <given-names>OE</given-names></name><name><surname>Smith</surname> <given-names>AC</given-names></name><name><surname>Gibson</surname> <given-names>CC</given-names></name><name><surname>Ling</surname> <given-names>J</given-names></name><name><surname>Passi</surname> <given-names>SF</given-names></name><name><surname>Stratman</surname> <given-names>AN</given-names></name><name><surname>Sacharidou</surname> <given-names>A</given-names></name><name><surname>Revelo</surname> <given-names>MP</given-names></name><name><surname>Grossmann</surname> <given-names>AH</given-names></name><name><surname>Diakos</surname> <given-names>NA</given-names></name><name><surname>Davis</surname> <given-names>GE</given-names></name><name><surname>Metzstein</surname> <given-names>MM</given-names></name><name><surname>Whitehead</surname> <given-names>KJ</given-names></name><name><surname>Li</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice</article-title><source>Journal of Clinical Investigation</source><volume>121</volume><fpage>1871</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1172/JCI44393</pub-id><pub-id pub-id-type="pmid">21490399</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiplunkar</surname> <given-names>AR</given-names></name><name><surname>Curtis</surname> <given-names>BC</given-names></name><name><surname>Eades</surname> <given-names>GL</given-names></name><name><surname>Kane</surname> <given-names>MS</given-names></name><name><surname>Fox</surname> <given-names>SJ</given-names></name><name><surname>Haar</surname> <given-names>JL</given-names></name><name><surname>Lloyd</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The Krüppel-like factor 2 and Krüppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis</article-title><source>BMC Developmental Biology</source><volume>13</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/1471-213X-13-40</pub-id><pub-id pub-id-type="pmid">24261709</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullere</surname> <given-names>X</given-names></name><name><surname>Plovie</surname> <given-names>E</given-names></name><name><surname>Bennett</surname> <given-names>PM</given-names></name><name><surname>MacRae</surname> <given-names>CA</given-names></name><name><surname>Mayadas</surname> <given-names>TN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3</article-title><source>PNAS</source><volume>112</volume><fpage>14284</fpage><lpage>14289</lpage><pub-id pub-id-type="doi">10.1073/pnas.1510495112</pub-id><pub-id pub-id-type="pmid">26540726</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname> <given-names>RJ</given-names></name><name><surname>van Soest</surname> <given-names>S</given-names></name><name><surname>Fontijn</surname> <given-names>RD</given-names></name><name><surname>Salamanca</surname> <given-names>S</given-names></name><name><surname>de Groot</surname> <given-names>PG</given-names></name><name><surname>VanBavel</surname> <given-names>E</given-names></name><name><surname>Pannekoek</surname> <given-names>H</given-names></name><name><surname>Horrevoets</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2)</article-title><source>Blood</source><volume>100</volume><fpage>1689</fpage><lpage>1698</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-01-0046</pub-id><pub-id pub-id-type="pmid">12176889</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname> <given-names>RJ</given-names></name><name><surname>van Thienen</surname> <given-names>JV</given-names></name><name><surname>Rohlena</surname> <given-names>J</given-names></name><name><surname>de Jager</surname> <given-names>SC</given-names></name><name><surname>Elderkamp</surname> <given-names>YW</given-names></name><name><surname>Seppen</surname> <given-names>J</given-names></name><name><surname>de Vries</surname> <given-names>CJ</given-names></name><name><surname>Biessen</surname> <given-names>EA</given-names></name><name><surname>van Berkel</surname> <given-names>TJ</given-names></name><name><surname>Pannekoek</surname> <given-names>H</given-names></name><name><surname>Horrevoets</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes</article-title><source>The American Journal of Pathology</source><volume>167</volume><fpage>609</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)63002-7</pub-id><pub-id pub-id-type="pmid">16049344</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drew</surname> <given-names>BA</given-names></name><name><surname>Burow</surname> <given-names>ME</given-names></name><name><surname>Beckman</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MEK5/ERK5 pathway: the first fifteen years</article-title><source>Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</source><volume>1825</volume><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2011.10.002</pub-id><pub-id pub-id-type="pmid">22020294</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driever</surname> <given-names>W</given-names></name><name><surname>Solnica-Krezel</surname> <given-names>L</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name><name><surname>Neuhauss</surname> <given-names>SC</given-names></name><name><surname>Malicki</surname> <given-names>J</given-names></name><name><surname>Stemple</surname> <given-names>DL</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Zwartkruis</surname> <given-names>F</given-names></name><name><surname>Abdelilah</surname> <given-names>S</given-names></name><name><surname>Rangini</surname> <given-names>Z</given-names></name><name><surname>Belak</surname> <given-names>J</given-names></name><name><surname>Boggs</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A genetic screen for mutations affecting embryogenesis in zebrafish</article-title><source>Development</source><volume>123</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(00)00406-8</pub-id><pub-id pub-id-type="pmid">9007227</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faurobert</surname> <given-names>E</given-names></name><name><surname>Rome</surname> <given-names>C</given-names></name><name><surname>Lisowska</surname> <given-names>J</given-names></name><name><surname>Manet-Dupé</surname> <given-names>S</given-names></name><name><surname>Boulday</surname> <given-names>G</given-names></name><name><surname>Malbouyres</surname> <given-names>M</given-names></name><name><surname>Balland</surname> <given-names>M</given-names></name><name><surname>Bouin</surname> <given-names>AP</given-names></name><name><surname>Kéramidas</surname> <given-names>M</given-names></name><name><surname>Bouvard</surname> <given-names>D</given-names></name><name><surname>Coll</surname> <given-names>JL</given-names></name><name><surname>Ruggiero</surname> <given-names>F</given-names></name><name><surname>Tournier-Lasserve</surname> <given-names>E</given-names></name><name><surname>Albiges-Rizo</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling</article-title><source>The Journal of Cell Biology</source><volume>202</volume><fpage>545</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1083/jcb.201303044</pub-id><pub-id pub-id-type="pmid">23918940</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gingras</surname> <given-names>AR</given-names></name><name><surname>Liu</surname> <given-names>JJ</given-names></name><name><surname>Ginsberg</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structural basis of the junctional anchorage of the cerebral cavernous malformations complex</article-title><source>The Journal of Cell Biology</source><volume>199</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1083/jcb.201205109</pub-id><pub-id pub-id-type="pmid">23007647</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groenendijk</surname> <given-names>BC</given-names></name><name><surname>Hierck</surname> <given-names>BP</given-names></name><name><surname>Gittenberger-De Groot</surname> <given-names>AC</given-names></name><name><surname>Poelmann</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Development-related changes in the expression of shear stress responsive genes KLF-2, ET-1, and NOS-3 in the developing cardiovascular system of chicken embryos</article-title><source>Developmental Dynamics</source><volume>230</volume><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20029</pub-id><pub-id pub-id-type="pmid">15108309</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groenendijk</surname> <given-names>BC</given-names></name><name><surname>Hierck</surname> <given-names>BP</given-names></name><name><surname>Vrolijk</surname> <given-names>J</given-names></name><name><surname>Baiker</surname> <given-names>M</given-names></name><name><surname>Pourquie</surname> <given-names>MJ</given-names></name><name><surname>Gittenberger-de Groot</surname> <given-names>AC</given-names></name><name><surname>Poelmann</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Changes in shear stress-related gene expression after experimentally altered venous return in the chicken embryo</article-title><source>Circulation Research</source><volume>96</volume><fpage>1291</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000171901.40952.0d</pub-id><pub-id pub-id-type="pmid">15920020</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haack</surname> <given-names>T</given-names></name><name><surname>Abdelilah-Seyfried</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The force within: endocardial development, mechanotransduction and signalling during cardiac morphogenesis</article-title><source>Development</source><volume>143</volume><fpage>373</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1242/dev.131425</pub-id><pub-id pub-id-type="pmid">26839341</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckel</surname> <given-names>E</given-names></name><name><surname>Boselli</surname> <given-names>F</given-names></name><name><surname>Roth</surname> <given-names>S</given-names></name><name><surname>Krudewig</surname> <given-names>A</given-names></name><name><surname>Belting</surname> <given-names>HG</given-names></name><name><surname>Charvin</surname> <given-names>G</given-names></name><name><surname>Vermot</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oscillatory Flow Modulates Mechanosensitive klf2a Expression through trpv4 and trpp2 during Heart Valve Development</article-title><source>Current Biology</source><volume>25</volume><fpage>1354</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.03.038</pub-id><pub-id pub-id-type="pmid">25959969</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hove</surname> <given-names>JR</given-names></name><name><surname>Köster</surname> <given-names>RW</given-names></name><name><surname>Forouhar</surname> <given-names>AS</given-names></name><name><surname>Acevedo-Bolton</surname> <given-names>G</given-names></name><name><surname>Fraser</surname> <given-names>SE</given-names></name><name><surname>Gharib</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis</article-title><source>Nature</source><volume>421</volume><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/nature01282</pub-id><pub-id pub-id-type="pmid">12520305</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>SW</given-names></name><name><surname>Beis</surname> <given-names>D</given-names></name><name><surname>Mitchell</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cellular and molecular analyses of vascular tube and lumen formation in zebrafish</article-title><source>Development</source><volume>132</volume><fpage>5199</fpage><lpage>5209</lpage><pub-id pub-id-type="doi">10.1242/dev.02087</pub-id><pub-id pub-id-type="pmid">16251212</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jowett</surname> <given-names>T</given-names></name><name><surname>Lettice</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Whole-mount in situ hybridizations on zebrafish embryos using a mixture of digoxigenin- and fluorescein-labelled probes</article-title><source>Trends in Genetics</source><volume>10</volume><fpage>73</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/0168-9525(94)90220-8</pub-id><pub-id pub-id-type="pmid">8178366</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleaveland</surname> <given-names>B</given-names></name><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>JJ</given-names></name><name><surname>Blum</surname> <given-names>Y</given-names></name><name><surname>Tung</surname> <given-names>JJ</given-names></name><name><surname>Zou</surname> <given-names>Z</given-names></name><name><surname>Sweeney</surname> <given-names>SM</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Lu</surname> <given-names>MM</given-names></name><name><surname>Zhou</surname> <given-names>D</given-names></name><name><surname>Kitajewski</surname> <given-names>J</given-names></name><name><surname>Affolter</surname> <given-names>M</given-names></name><name><surname>Ginsberg</surname> <given-names>MH</given-names></name><name><surname>Kahn</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway</article-title><source>Nature Medicine</source><volume>15</volume><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1038/nm.1918</pub-id><pub-id pub-id-type="pmid">19151727</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagendijk</surname> <given-names>AK</given-names></name><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Burkhard</surname> <given-names>SB</given-names></name><name><surname>Bakkers</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production</article-title><source>Circulation Research</source><volume>109</volume><fpage>649</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.247635</pub-id><pub-id pub-id-type="pmid">21778427</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Yu</surname> <given-names>Q</given-names></name><name><surname>Shin</surname> <given-names>JT</given-names></name><name><surname>Sebzda</surname> <given-names>E</given-names></name><name><surname>Bertozzi</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Mericko</surname> <given-names>P</given-names></name><name><surname>Stadtfeld</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>D</given-names></name><name><surname>Cheng</surname> <given-names>L</given-names></name><name><surname>Graf</surname> <given-names>T</given-names></name><name><surname>MacRae</surname> <given-names>CA</given-names></name><name><surname>Lepore</surname> <given-names>JJ</given-names></name><name><surname>Lo</surname> <given-names>CW</given-names></name><name><surname>Kahn</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Klf2 is an essential regulator of vascular hemodynamic forces in vivo</article-title><source>Developmental Cell</source><volume>11</volume><fpage>845</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.09.006</pub-id><pub-id pub-id-type="pmid">17141159</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Schmittgen</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mably</surname> <given-names>JD</given-names></name><name><surname>Mohideen</surname> <given-names>MA</given-names></name><name><surname>Burns</surname> <given-names>CG</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>heart of glass regulates the concentric growth of the heart in zebrafish</article-title><source>Current Biology</source><volume>13</volume><fpage>2138</fpage><lpage>2147</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2003.11.055</pub-id><pub-id pub-id-type="pmid">14680629</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mably</surname> <given-names>JD</given-names></name><name><surname>Chuang</surname> <given-names>LP</given-names></name><name><surname>Serluca</surname> <given-names>FC</given-names></name><name><surname>Mohideen</surname> <given-names>MA</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish</article-title><source>Development</source><volume>133</volume><fpage>3139</fpage><lpage>3146</lpage><pub-id pub-id-type="doi">10.1242/dev.02469</pub-id><pub-id pub-id-type="pmid">16873582</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macek Jilkova</surname> <given-names>Z</given-names></name><name><surname>Lisowska</surname> <given-names>J</given-names></name><name><surname>Manet</surname> <given-names>S</given-names></name><name><surname>Verdier</surname> <given-names>C</given-names></name><name><surname>Deplano</surname> <given-names>V</given-names></name><name><surname>Geindreau</surname> <given-names>C</given-names></name><name><surname>Faurobert</surname> <given-names>E</given-names></name><name><surname>Albigès-Rizo</surname> <given-names>C</given-names></name><name><surname>Duperray</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CCM proteins control endothelial β1 integrin dependent response to shear stress</article-title><source>Biology Open</source><volume>3</volume><fpage>1228</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1242/bio.201410132</pub-id><pub-id pub-id-type="pmid">25432514</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddaluno</surname> <given-names>L</given-names></name><name><surname>Rudini</surname> <given-names>N</given-names></name><name><surname>Cuttano</surname> <given-names>R</given-names></name><name><surname>Bravi</surname> <given-names>L</given-names></name><name><surname>Giampietro</surname> <given-names>C</given-names></name><name><surname>Corada</surname> <given-names>M</given-names></name><name><surname>Ferrarini</surname> <given-names>L</given-names></name><name><surname>Orsenigo</surname> <given-names>F</given-names></name><name><surname>Papa</surname> <given-names>E</given-names></name><name><surname>Boulday</surname> <given-names>G</given-names></name><name><surname>Tournier-Lasserve</surname> <given-names>E</given-names></name><name><surname>Chapon</surname> <given-names>F</given-names></name><name><surname>Richichi</surname> <given-names>C</given-names></name><name><surname>Retta</surname> <given-names>SF</given-names></name><name><surname>Lampugnani</surname> <given-names>MG</given-names></name><name><surname>Dejana</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>EndMT contributes to the onset and progression of cerebral cavernous malformations</article-title><source>Nature</source><volume>498</volume><fpage>492</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/nature12207</pub-id><pub-id pub-id-type="pmid">23748444</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCloy</surname> <given-names>RA</given-names></name><name><surname>Rogers</surname> <given-names>S</given-names></name><name><surname>Caldon</surname> <given-names>CE</given-names></name><name><surname>Lorca</surname> <given-names>T</given-names></name><name><surname>Castro</surname> <given-names>A</given-names></name><name><surname>Burgess</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Partial inhibition of Cdk1 in G<sub>2</sub> phase overrides the SAC and decouples mitotic events</article-title><source>Cell Cycle</source><volume>13</volume><fpage>1400</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.4161/cc.28401</pub-id><pub-id pub-id-type="pmid">24626186</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Münch</surname> <given-names>J</given-names></name><name><surname>Grivas</surname> <given-names>D</given-names></name><name><surname>González-Rajal</surname> <given-names>Á</given-names></name><name><surname>Torregrosa-Carrión</surname> <given-names>R</given-names></name><name><surname>de la Pompa</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Notch signalling restricts inflammation and serpine1 expression in the dynamic endocardium of the regenerating zebrafish heart</article-title><source>Development</source><volume>144</volume><fpage>1425</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1242/dev.143362</pub-id><pub-id pub-id-type="pmid">28242613</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoli</surname> <given-names>S</given-names></name><name><surname>Standley</surname> <given-names>C</given-names></name><name><surname>Walker</surname> <given-names>P</given-names></name><name><surname>Hurlstone</surname> <given-names>A</given-names></name><name><surname>Fogarty</surname> <given-names>KE</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis</article-title><source>Nature</source><volume>464</volume><fpage>1196</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1038/nature08889</pub-id><pub-id pub-id-type="pmid">20364122</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ninov</surname> <given-names>N</given-names></name><name><surname>Borius</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Different levels of Notch signaling regulate quiescence, renewal and differentiation in pancreatic endocrine progenitors</article-title><source>Development</source><volume>139</volume><fpage>1557</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1242/dev.076000</pub-id><pub-id pub-id-type="pmid">22492351</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novodvorsky</surname> <given-names>P</given-names></name><name><surname>Chico</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of the transcription factor KLF2 in vascular development and disease</article-title><source>Progress in Molecular Biology and Translational Science</source><volume>124</volume><fpage>155</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-386930-2.00007-0</pub-id><pub-id pub-id-type="pmid">24751430</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parmar</surname> <given-names>KM</given-names></name><name><surname>Nambudiri</surname> <given-names>V</given-names></name><name><surname>Dai</surname> <given-names>G</given-names></name><name><surname>Larman</surname> <given-names>HB</given-names></name><name><surname>Gimbrone</surname> <given-names>MA</given-names></name><name><surname>García-Cardeña</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Statins exert endothelial atheroprotective effects via the KLF2 transcription factor</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>26714</fpage><lpage>26719</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500144200</pub-id><pub-id pub-id-type="pmid">15878865</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestel</surname> <given-names>J</given-names></name><name><surname>Ramadass</surname> <given-names>R</given-names></name><name><surname>Gauvrit</surname> <given-names>S</given-names></name><name><surname>Helker</surname> <given-names>C</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Real-time 3D visualization of cellular rearrangements during cardiac valve formation</article-title><source>Development</source><volume>143</volume><fpage>2217</fpage><lpage>2227</lpage><pub-id pub-id-type="doi">10.1242/dev.133272</pub-id><pub-id pub-id-type="pmid">27302398</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renz</surname> <given-names>M</given-names></name><name><surname>Otten</surname> <given-names>C</given-names></name><name><surname>Faurobert</surname> <given-names>E</given-names></name><name><surname>Rudolph</surname> <given-names>F</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Boulday</surname> <given-names>G</given-names></name><name><surname>Duchene</surname> <given-names>J</given-names></name><name><surname>Mickoleit</surname> <given-names>M</given-names></name><name><surname>Dietrich</surname> <given-names>AC</given-names></name><name><surname>Ramspacher</surname> <given-names>C</given-names></name><name><surname>Steed</surname> <given-names>E</given-names></name><name><surname>Manet-Dupé</surname> <given-names>S</given-names></name><name><surname>Benz</surname> <given-names>A</given-names></name><name><surname>Hassel</surname> <given-names>D</given-names></name><name><surname>Vermot</surname> <given-names>J</given-names></name><name><surname>Huisken</surname> <given-names>J</given-names></name><name><surname>Tournier-Lasserve</surname> <given-names>E</given-names></name><name><surname>Felbor</surname> <given-names>U</given-names></name><name><surname>Sure</surname> <given-names>U</given-names></name><name><surname>Albiges-Rizo</surname> <given-names>C</given-names></name><name><surname>Abdelilah-Seyfried</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins</article-title><source>Developmental Cell</source><volume>32</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.12.016</pub-id><pub-id pub-id-type="pmid">25625207</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riant</surname> <given-names>F</given-names></name><name><surname>Bergametti</surname> <given-names>F</given-names></name><name><surname>Ayrignac</surname> <given-names>X</given-names></name><name><surname>Boulday</surname> <given-names>G</given-names></name><name><surname>Tournier-Lasserve</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Recent insights into cerebral cavernous malformations: the molecular genetics of CCM</article-title><source>FEBS Journal</source><volume>277</volume><fpage>1070</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07535.x</pub-id><pub-id pub-id-type="pmid">20096038</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname> <given-names>BA</given-names></name><name><surname>Force</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale</article-title><source>Physiological Reviews</source><volume>90</volume><fpage>1507</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1152/physrev.00054.2009</pub-id><pub-id pub-id-type="pmid">20959622</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherz</surname> <given-names>PJ</given-names></name><name><surname>Huisken</surname> <given-names>J</given-names></name><name><surname>Sahai-Hernandez</surname> <given-names>P</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-speed imaging of developing heart valves reveals interplay of morphogenesis and function</article-title><source>Development</source><volume>135</volume><fpage>1179</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1242/dev.010694</pub-id><pub-id pub-id-type="pmid">18272595</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedletcaia</surname> <given-names>A</given-names></name><name><surname>Evans</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Heart chamber size in zebrafish is regulated redundantly by duplicated tbx2 genes</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>1548</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22622</pub-id><pub-id pub-id-type="pmid">21448936</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehnert</surname> <given-names>AJ</given-names></name><name><surname>Huq</surname> <given-names>A</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name><name><surname>Walker</surname> <given-names>C</given-names></name><name><surname>Fishman</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cardiac troponin T is essential in sarcomere assembly and cardiac contractility</article-title><source>Nature Genetics</source><volume>31</volume><fpage>106</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1038/ng875</pub-id><pub-id pub-id-type="pmid">11967535</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steed</surname> <given-names>E</given-names></name><name><surname>Faggianelli</surname> <given-names>N</given-names></name><name><surname>Roth</surname> <given-names>S</given-names></name><name><surname>Ramspacher</surname> <given-names>C</given-names></name><name><surname>Concordet</surname> <given-names>JP</given-names></name><name><surname>Vermot</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>klf2a couples mechanotransduction and zebrafish valve morphogenesis through fibronectin synthesis</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11646</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11646</pub-id><pub-id pub-id-type="pmid">27221222</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlik</surname> <given-names>MT</given-names></name><name><surname>Abell</surname> <given-names>AN</given-names></name><name><surname>Johnson</surname> <given-names>NL</given-names></name><name><surname>Sun</surname> <given-names>W</given-names></name><name><surname>Cuevas</surname> <given-names>BD</given-names></name><name><surname>Lobel-Rice</surname> <given-names>KE</given-names></name><name><surname>Horne</surname> <given-names>EA</given-names></name><name><surname>Dell'Acqua</surname> <given-names>ML</given-names></name><name><surname>Johnson</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock</article-title><source>Nature Cell Biology</source><volume>5</volume><fpage>1104</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1038/ncb1071</pub-id><pub-id pub-id-type="pmid">14634666</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermot</surname> <given-names>J</given-names></name><name><surname>Forouhar</surname> <given-names>AS</given-names></name><name><surname>Liebling</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Plummer</surname> <given-names>D</given-names></name><name><surname>Gharib</surname> <given-names>M</given-names></name><name><surname>Fraser</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Reversing blood flows act through klf2a to ensure normal valvulogenesis in the developing heart</article-title><source>PLoS Biology</source><volume>7</volume><elocation-id>e1000246</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000246</pub-id><pub-id pub-id-type="pmid">19924233</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname> <given-names>EC</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish</article-title><source>Science</source><volume>293</volume><fpage>1670</fpage><lpage>1673</lpage><pub-id pub-id-type="doi">10.1126/science.293.5535.1670</pub-id><pub-id pub-id-type="pmid">11533493</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westerfield</surname> <given-names>M</given-names></name><name><surname>Doerry</surname> <given-names>E</given-names></name><name><surname>Kirkpatrick</surname> <given-names>AE</given-names></name><name><surname>Driever</surname> <given-names>W</given-names></name><name><surname>Douglas</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>An on-line database for zebrafish development and genetics research</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>8</volume><fpage>477</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1006/scdb.1997.0173</pub-id><pub-id pub-id-type="pmid">9441953</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname> <given-names>KJ</given-names></name><name><surname>Chan</surname> <given-names>AC</given-names></name><name><surname>Navankasattusas</surname> <given-names>S</given-names></name><name><surname>Koh</surname> <given-names>W</given-names></name><name><surname>London</surname> <given-names>NR</given-names></name><name><surname>Ling</surname> <given-names>J</given-names></name><name><surname>Mayo</surname> <given-names>AH</given-names></name><name><surname>Drakos</surname> <given-names>SG</given-names></name><name><surname>Jones</surname> <given-names>CA</given-names></name><name><surname>Zhu</surname> <given-names>W</given-names></name><name><surname>Marchuk</surname> <given-names>DA</given-names></name><name><surname>Davis</surname> <given-names>GE</given-names></name><name><surname>Li</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases</article-title><source>Nature Medicine</source><volume>15</volume><fpage>177</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/nm.1911</pub-id><pub-id pub-id-type="pmid">19151728</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wüstehube</surname> <given-names>J</given-names></name><name><surname>Bartol</surname> <given-names>A</given-names></name><name><surname>Liebler</surname> <given-names>SS</given-names></name><name><surname>Brütsch</surname> <given-names>R</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Felbor</surname> <given-names>U</given-names></name><name><surname>Sure</surname> <given-names>U</given-names></name><name><surname>Augustin</surname> <given-names>HG</given-names></name><name><surname>Fischer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling</article-title><source>PNAS</source><volume>107</volume><fpage>12640</fpage><lpage>12645</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000132107</pub-id><pub-id pub-id-type="pmid">20616044</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Boerm</surname> <given-names>M</given-names></name><name><surname>McCarty</surname> <given-names>M</given-names></name><name><surname>Bucana</surname> <given-names>C</given-names></name><name><surname>Fidler</surname> <given-names>IJ</given-names></name><name><surname>Zhuang</surname> <given-names>Y</given-names></name><name><surname>Su</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mekk3 is essential for early embryonic cardiovascular development</article-title><source>Nature Genetics</source><volume>24</volume><fpage>309</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1038/73550</pub-id><pub-id pub-id-type="pmid">10700190</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoruk</surname> <given-names>B</given-names></name><name><surname>Gillers</surname> <given-names>BS</given-names></name><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Scott</surname> <given-names>IC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease</article-title><source>Developmental Biology</source><volume>362</volume><fpage>121</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.12.006</pub-id><pub-id pub-id-type="pmid">22182521</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname> <given-names>C</given-names></name><name><surname>Sandalcioglu</surname> <given-names>IE</given-names></name><name><surname>Dammann</surname> <given-names>P</given-names></name><name><surname>Felbor</surname> <given-names>U</given-names></name><name><surname>Sure</surname> <given-names>U</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations</article-title><source>Journal of Cellular and Molecular Medicine</source><volume>17</volume><fpage>407</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1111/jcmm.12022</pub-id><pub-id pub-id-type="pmid">23388056</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Di Lorenzo</surname> <given-names>A</given-names></name><name><surname>Kleaveland</surname> <given-names>B</given-names></name><name><surname>Zou</surname> <given-names>Z</given-names></name><name><surname>Seiler</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Cheng</surname> <given-names>L</given-names></name><name><surname>Xiao</surname> <given-names>J</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Pack</surname> <given-names>MA</given-names></name><name><surname>Sessa</surname> <given-names>WC</given-names></name><name><surname>Kahn</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>2795</fpage><lpage>2804</lpage><pub-id pub-id-type="doi">10.1172/JCI39679</pub-id><pub-id pub-id-type="pmid">20592472</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Riant</surname> <given-names>F</given-names></name><name><surname>Bergametti</surname> <given-names>F</given-names></name><name><surname>Myers</surname> <given-names>CD</given-names></name><name><surname>Tang</surname> <given-names>AT</given-names></name><name><surname>Kleaveland</surname> <given-names>B</given-names></name><name><surname>Pan</surname> <given-names>W</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Tournier-Lasserve</surname> <given-names>E</given-names></name><name><surname>Kahn</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cerebral cavernous malformations arise independent of the heart of glass receptor</article-title><source>Stroke</source><volume>45</volume><fpage>1505</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.114.004809</pub-id><pub-id pub-id-type="pmid">24643410</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Rawnsley</surname> <given-names>DR</given-names></name><name><surname>Goddard</surname> <given-names>LM</given-names></name><name><surname>Pan</surname> <given-names>W</given-names></name><name><surname>Cao</surname> <given-names>XJ</given-names></name><name><surname>Jakus</surname> <given-names>Z</given-names></name><name><surname>Zheng</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Arthur</surname> <given-names>JS</given-names></name><name><surname>Whitehead</surname> <given-names>KJ</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Garcia</surname> <given-names>BA</given-names></name><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Kahn</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression</article-title><source>Developmental Cell</source><volume>32</volume><fpage>168</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.12.009</pub-id><pub-id pub-id-type="pmid">25625206</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Tang</surname> <given-names>AT</given-names></name><name><surname>Wong</surname> <given-names>WY</given-names></name><name><surname>Bamezai</surname> <given-names>S</given-names></name><name><surname>Goddard</surname> <given-names>LM</given-names></name><name><surname>Shenkar</surname> <given-names>R</given-names></name><name><surname>Zhou</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Wright</surname> <given-names>AC</given-names></name><name><surname>Foley</surname> <given-names>M</given-names></name><name><surname>Arthur</surname> <given-names>JS</given-names></name><name><surname>Whitehead</surname> <given-names>KJ</given-names></name><name><surname>Awad</surname> <given-names>IA</given-names></name><name><surname>Li</surname> <given-names>DY</given-names></name><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Kahn</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling</article-title><source>Nature</source><volume>532</volume><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/nature17178</pub-id><pub-id pub-id-type="pmid">27027284</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.28939.018</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Yelon</surname><given-names>Deborah</given-names></name><role>Reviewing Editor</role><aff id="aff4"><institution>University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;CCM proteins control endocardial mechanosensitivity during zebrafish valvulogenesis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Ian C Scott (Reviewer #1); Dimitris Beis (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In this manuscript, Donat and colleagues investigate the roles of the CCM-associated genes <italic>heg1</italic> and <italic>krit1</italic> during atrioventricular valve leaflet formation in the endocardium of the developing zebrafish heart. The authors first show that <italic>heg1</italic> transcripts are positively regulated by blood flow. Heg1 in turn acts to stabilize Krit1, and these genes repress <italic>klf2a</italic>, a major mechanosensitive gene. As a result, the absence of Heg1 and Krit1 function leads to overexpression of <italic>klf2a</italic> and mis-activation of Notch signaling throughout the endocardium, which impairs valve leaflet formation. Overall, the authors present a model where Heg1/Krit1/CCM2 &quot;establishes a negative feedback loop that desensitizes endothelial cells to blood flow-induced mechanosensitive signaling by dampening expression levels of Klf2a&quot;. As the links between Heg/Krit1/CCM2 and Klf2a/Notch have been previously described (including by Dr. Abdelilah-Seyfried), the most novel element of this model is the implication of the Heg1/Krit1/CCM2 pathway in valve leaflet development, with its potential function being a means to fine-tune the response to flow during valve development. This is an interesting model, particularly in terms of providing a mechanistic link between blood flow and specific features of cardiac morphology, and it would therefore be of interest to the readers of <italic>eLife</italic>. However, there are a number of caveats inherent in the authors' experimental design and results, and further work is needed to fully support the authors' interpretations and conclusions.</p><p>Essential revisions:</p><p>1) Most of the expression data is supported by quantitative PCR (i.e. <xref ref-type="fig" rid="fig1">Figure 1A and B</xref>, <xref ref-type="fig" rid="fig2">Figure 2A</xref>) on vascular endothelial cells. This technique, although quantitative, does not provide any information about the localization of the expression of the studied genes. Whole mount in situ hybridizations would greatly help to reveal spatial differences in the expression of these genes, particularly in the heart. Ideally, qPCR should be performed in isolated AV endocardial cells, given the focus of the manuscript.</p><p>2) <xref ref-type="fig" rid="fig1">Figure 1</xref>: The stabilization of Krit1 protein by Heg1 is shown in trunk vessels, yet this research is focused on valve development. This should be analyzed in the AVC. Additionally, the conclusion that Heg1 stabilizes the levels of Krit1 is based on an experiment using a Gal4-UAS system that overexpresses EGFP-Krit1. Thus, it is somewhat challenging to draw a meaningful conclusion about the ability of Heg1 to stabilize Krit1 protein levels from these non-physiologic studies. Western analysis would be a better approach in determining Krit1 levels in <italic>heg1</italic> morphant and wild-type hearts.</p><p>3) <xref ref-type="fig" rid="fig2">Figure 2</xref>: The evidence that &quot;endocardial cells become desensitized to blood flow-induced mechanosensitive signaling when <italic>krit1</italic> or <italic>ccm2</italic> are overexpressed&quot; is not compelling. The authors state that hearts with CCM1/2 overexpression resemble silent heart morphant (no flow) hearts, and that the atrium/ventricle flt1:YFP expression ratio is increased over time, but this may simply reflect aberrant heart development rather than a specific desensitization. In addition, the authors' use of flt1:YFP as a reporter of flow responses is based on the prior studies of Hogan, which were focused on the vascular endothelium. However, the ability of this line to sense hemodynamic flow has not been validated in the heart. Particularly concerning is the expression of flt1:YFP in the ventricle of the <italic>tnnt2a</italic> MO hearts. Is this endocardial or myocardial expression that is observed? Using endocardial and myocardial lines in combination with the flt1:YFP might help resolve these issues. Performing studies to validate the ability of this line to sense hemodynamic flow in the heart would help with interpretation of studies as well.</p><p>4) Although the authors conclude that <italic>notch1b</italic> is expressed throughout the endocardium in the <italic>krit1</italic> mutant, the <italic>notch1b</italic> in situs and the notch reporter do not support this interpretation. It is possible that the AVC region is expanded in the <italic>krit1</italic> mutant. How are the authors defining the AVC? Without atrial, ventricular or AV boundary markers, it is difficult to determine where the endocardial cushions are in the <italic>krit1</italic> mutant. Providing this data would help with interpretation of the studies. In addition, it would be useful to examine the <italic>ccm2</italic> mutant in addition to the <italic>krit1</italic> mutant, to strengthen the demonstration of how loss of ccm genes affects endocardial notch activation.</p><p>5) The studies on the overexpression of exogenous mRNA of egfp-<italic>krit1</italic> in the <italic>krit1</italic> mutant do not have sufficient controls and validation of assays to allow for a meaningful interpretation. Many assumptions are made in order for the authors to come to their conclusions. For example, there is insufficient evidence to show that injected mRNA is no longer present at 55 or 96 hpf. Moreover, over/mis-expression of <italic>krit1</italic> may lead to a phenotype irrespective of the <italic>krit1</italic> mutant. In fact, the phenotype is surprisingly similar to that found in late Notch inhibition and in the <italic>klf2a</italic> mutant (Beis et al., 2005, Steed et al., 2016).</p><p>6) It would be beneficial to provide further support for the requirement of Krit1 for the generation of abluminal cell fates during valvulogenesis. The transient rescue of <italic>krit1</italic> mutants allows AVC endocardial cells to differentiate properly at 48 hpf. Alcam levels do appear higher in most AVC cells at 96 hpf (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, duplicated in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4C</xref>’) but the morphology of the AV valve seems to also include abluminal cells (cardiac jelly cells or mesenchymal-like cells). Repeating the experiment in combination with a Wnt signaling readout (TCF reporter or other) and/or using the inducible <italic>hs</italic>:Krit1 line in the <italic>krit1</italic> mutant background to better control <italic>krit1</italic> levels, would strengthen their claim.</p><p>7) The model in <xref ref-type="fig" rid="fig5">Figure 5</xref> is somewhat confusing. It might be helpful to show a model for the <italic>ccm</italic> mutant with blood flow and then when there is no blood flow. Based on the authors' current model, it seems that Notch would be activated throughout the endocardium in the <italic>ccm</italic> mutant with blood flow since <italic>ccm</italic> is not present to block <italic>klf2a</italic> expression. If this is the case, this seems to be in conflict with the current <italic>ccm</italic> mutant and no blood flow model where the lack of blood flow would lead to no <italic>klf2a</italic> expression and downstream Notch signaling. Additionally, the authors also speculate &quot;Notch-mediated lateral inhibition&quot; in their model; however, there is insufficient data to support this notion. This should be modified in the model.</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><p>Thank you for resubmitting the revised version of your manuscript entitled &quot;CCM proteins control endocardial mechanosensitivity during zebrafish valvulogenesis&quot; for further consideration at <italic>eLife</italic>. Your revised manuscript has now been favorably evaluated by Marianne Bronner (Senior editor), a Reviewing editor, and its original three reviewers.</p><p>The reviewers appreciate the improvements made in your revised manuscript, but they have also raised several issues that remain to be addressed through further revision, as outlined below.</p><p>1) The Abstract is confusing in its current form, as it is not made clear in which direction many of the genes/pathways mentioned affect outcome. As an example: does the abstract make it clear whether <italic>heg1</italic> expression is increased or reduced by low blood flow? The last paragraph of the Introduction section is similarly vague and does not refer to the <italic>heg1</italic> results.</p><p>2) In the Title, it may be better to mention CCM1/2, since CCM3 is not addressed in this study. Non-CCM experts may not appreciate what &quot;CCM proteins&quot; are.</p><p>3) From the data shown in the revised manuscript, it is not clear whether <italic>heg1</italic> is expressed in the endocardium or the myocardium, although it is stated that it is expressed in the endocardium. Can the evidence for this be clarified?</p><p>4) The use of the Notch reporter, in place of the previous Flt reporter, to monitor flow response is appreciated. However, the images in <xref ref-type="fig" rid="fig2">Figure 2B–D</xref> are hard to interpret. Although the ratios measured by the authors (<xref ref-type="fig" rid="fig2">Figure 2E–F</xref>) demonstrate the same trend following overexpression of Krit1 and Ccm2, the patterns of expression shown in <xref ref-type="fig" rid="fig2">Figure 2C–D</xref> seem markedly different; hard to interpret. This apparent discrepancy should be addressed. In addition, in light of recent studies showing myocardial Notch reporter activity in developing zebrafish hearts, it is unclear whether the Notch reporter activity shown here (and in <xref ref-type="fig" rid="fig4">Figure 4</xref>) is endocardial or myocardial. Can this be clarified?</p><p>5) The authors utilize Cdh5 as a marker for the lumenal side of the AV valve, but they do not cite references for its use as a lumenal marker. If they are introducing this marker here, its characterization as such should be clearly described.</p><p>6) In <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, the authors use a single marker (Myh6) to define the location of the AVC in <italic>krit1</italic> mutants. This marker indicates the edge of the atrium but isn't sufficient to demonstrate whether the AVC is or isn't expanded in the mutant hearts. Can the authors use specific AVC markers to indicate whether the AVC region is expanded in <italic>krit1</italic> mutants?</p><p>7) At the beginning of the Discussion section, the authors allude to evidence that Cdh5/VEcadherin plays into this pathway, but such evidence is not reported in this manuscript.</p><p>8) The new model figure is appreciated, but, in light of what is suggested by <xref ref-type="fig" rid="fig1">Figure 1</xref>, it does not address the effect of flow on Heg1 and Krit1 levels. This is confusing – can it be revised to include these elements of the model?</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.28939.019</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Most of the expression data is supported by quantitative PCR (i.e. <xref ref-type="fig" rid="fig1">Figure 1A and B</xref>, <xref ref-type="fig" rid="fig2">Figure 2A</xref>) on vascular endothelial cells. This technique, although quantitative, does not provide any information about the localization of the expression of the studied genes. Whole mount in situ hybridizations would greatly help to reveal spatial differences in the expression of these genes, particularly in the heart. Ideally, qPCR should be performed in isolated AV endocardial cells, given the focus of the manuscript.</p></disp-quote><p>Within the revised version of the manuscript, we now provide expression data of <italic>heg1</italic> mRNA (<xref ref-type="fig" rid="fig1">Figure 1—figure supplement 1</xref>). Consistent with a blood-flow responsive expression, <italic>heg1</italic> mRNA has a stronger expression at the AVC and in the ventricle at 48 hpf. In support of our finding, another study reported a similar pattern of <italic>heg1</italic> mRNA cardiac expression recently (Münch et al., 2017). We are now also referring to this work in our revised manuscript. The expression of <italic>krit1</italic> has been published previously (Mably et al.,2006) and, similar to that study, we have not found any regional expression of <italic>krit1</italic> that would point at a blood-flow responsive regulation. This finding is in tune with the fact that <italic>krit1</italic> mRNA levels are not affected in <italic>tnnt2a</italic> morphants as assayed by RT-qPCR. This lends further support to an important role particularly of <italic>heg1</italic> in response to biomechanical stimuli. The reviewers’ suggestion to use isolated AVC endocardial cells for RT-qPCR experiments is very good but technically very challenging. Unfortunately, we have not been able yet to establish a technology for AVC dissection.</p><disp-quote content-type="editor-comment"><p>2) <xref ref-type="fig" rid="fig1">Figure 1</xref>: The stabilization of Krit1 protein by Heg1 is shown in trunk vessels, yet this research is focused on valve development. This should be analyzed in the AVC. Additionally, the conclusion that Heg1 stabilizes the levels of Krit1 is based on an experiment using a Gal4-UAS system that overexpresses EGFP-Krit1. Thus, it is somewhat challenging to draw a meaningful conclusion about the ability of Heg1 to stabilize Krit1 protein levels from these non-physiologic studies. Western analysis would be a better approach in determining Krit1 levels in heg1 morphant and wild-type hearts.</p></disp-quote><p>Within revised <xref ref-type="fig" rid="fig1">Figure 1C–D</xref>, we now show that EGFP-Krit1 levels are significantly reduced within the heart. This finding is in tune with the changes of EGFP-Krit1 levels within the vasculature (now shown in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p><p>Due to the lack of an antibody that recognizes zebrafish Krit1, it has remained a challenge to quantify the physiological levels of Krit1 upon loss of Heg1. To assess physiological levels of Krit1, we therefore undertook mass spectrometric analyses of the cardiac proteome under WT and <italic>heg1</italic> mutant conditions (with 150 purified hearts per genetic condition and replicate) in an attempt to detect CCM complex proteins. Unfortunately, this approach was not sufficiently sensitive to detect Krit1 protein levels.</p><p>Faurobert and colleagues recently demonstrated that, similar to our findings, in HUVECs, a loss of CCM2 also causes a depletion of KRIT1 (Faurobert et al., (2013).</p><disp-quote content-type="editor-comment"><p>3) <xref ref-type="fig" rid="fig2">Figure 2</xref>: The evidence that &quot;endocardial cells become desensitized to blood flow-induced mechanosensitive signaling when krit1 or ccm2 are overexpressed&quot; is not compelling. The authors state that hearts with CCM1/2 overexpression resemble silent heart morphant (no flow) hearts, and that the atrium/ventricle flt1:YFP expression ratio is increased over time, but this may simply reflect aberrant heart development rather than a specific desensitization. In addition, the authors' use of flt1:YFP as a reporter of flow responses is based on the prior studies of Hogan, which were focused on the vascular endothelium. However, the ability of this line to sense hemodynamic flow has not been validated in the heart. Particularly concerning is the expression of flt1:YFP in the ventricle of the tnnt2a MO hearts. Is this endocardial or myocardial expression that is observed? Using endocardial and myocardial lines in combination with the flt1:YFP might help resolve these issues. Performing studies to validate the ability of this line to sense hemodynamic flow in the heart would help with interpretation of studies as well.</p></disp-quote><p>We agree with the reviewers that the ability of the Tg(flt1:YFP) line to sense the hemodynamic forces of blood flow has not previously been shown. Within the revised manuscript, we have now repeated the above experiments using the well-established blood flow-sensitive Notch reporter line <italic>Tg(EPV.Tp1-Mmu.Hbb:Venus-Mmu.Odc1)<sup>s940</sup> </italic>(Ninov et al., 2012). Within the revised manuscript, we now show that the forced overexpression of Krit1 or Ccm2 alters the expression of the <italic>Tg(EPV.Tp1-Mmu.Hbb:Venus-Mmu.Odc1)<sup>s940</sup></italic> reporter within the endocardium which, in WT, is particularly strong within the ventricle and AVC. Due to the overexpression of Krit1 or Ccm2, the expression from the <italic>Tg(TP1:VenusPEST)<sup>s940</sup></italic> reporter is weakened and not restricted to the ventricle and AVC region at 54 hpf (<xref ref-type="fig" rid="fig2">figure 2B–F</xref>). These expression changes of the Notch reporter line occur while blood flow is not obviously affected as assayed by visual inspection. Hence, we suggest that the blood flow responsiveness of endocardial cells is affected.</p><disp-quote content-type="editor-comment"><p>4) Although the authors conclude that notch1b is expressed throughout the endocardium in the krit1 mutant, the notch1b in situs and the notch reporter do not support this interpretation. It is possible that the AVC region is expanded in the krit1 mutant. How are the authors defining the AVC? Without atrial, ventricular or AV boundary markers, it is difficult to determine where the endocardial cushions are in the krit1 mutant. Providing this data would help with interpretation of the studies. In addition, it would be useful to examine the ccm2 mutant in addition to the krit1 mutant, to strengthen the demonstration of how loss of ccm genes affects endocardial notch activation.</p></disp-quote><p>To visualize the AVC region for a better assessment of the AVC endocardial Notch expression, we have counterstained the hearts using chamber-specific markers in WT and <italic>krit1</italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The fact that myocardial chamber identities are not affected in <italic>ccm</italic> mutants provides a strong boundary-marker for the AVC. Based on that sharply defined border between both chambers, we have assessed the endocardial Notch reporter expression which expands far beyond that boundary region.</p><p>We also agree with the reviewers that it is important to verify the results obtained in <italic>krit1</italic> mutants also in <italic>ccm2</italic> mutants. The appropriate results for these mutants are now shown for <italic>ccm2</italic> (<xref ref-type="fig" rid="fig4">Figure 4D,D</xref>’) and for <italic>krit1</italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). In both cases, the domain of Notch signaling is expanded within the endocardium.</p><disp-quote content-type="editor-comment"><p>5) The studies on the overexpression of exogenous mRNA of egfp-krit1 in the krit1 mutant do not have sufficient controls and validation of assays to allow for a meaningful interpretation. Many assumptions are made in order for the authors to come to their conclusions. For example, there is insufficient evidence to show that injected mRNA is no longer present at 55 or 96 hpf. Moreover, over/mis-expression of krit1 may lead to a phenotype irrespective of the krit1 mutant. In fact, the phenotype is surprisingly similar to that found in late Notch inhibition and in the klf2a mutant (Beis et al., 2005, Steed et al., 2016).</p></disp-quote><p>We have now measured <italic>krit1</italic> mRNA levels over time and find that the levels are depleted by 96 hpf (shown in revised <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Since there is no evidence for EGFP-Krit1 protein levels at that stage (no EGFP detectable), the evidence is very strong that we are analyzing a <italic>krit1</italic> loss-of-function phenotype. In further support of this interpretation, the endocardial over proliferation phenotype that is associated with a loss of <italic>krit1</italic> becomes apparent by 55 hpf (shown in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><p>As the reviewers pointed out, there are some phenotypic similarities of the late <italic>krit1</italic> phenotype with the loss of Notch (Beis et al., 2005-this initial description of the Notch inhibited cardiac valve phenotype is now also cited and discussed within the revised manuscript) or loss of <italic>klf2a</italic> phenotypes (Steed et al., 2016). However, in our study, we show that not only <italic>klf2a</italic> mRNA levels are increased (<xref ref-type="fig" rid="fig3">Figure 3L</xref>) but also that Notch signaling is expressed in a larger domain throughout the endocardium in late loss of <italic>krit1</italic> conditions (<xref ref-type="fig" rid="fig4">Figure 4B</xref>; Figure 4—figure supplement 3B). Taken together this argues for an activated late Notch and Klf2a signaling that is causing the cardiac valve leaflet morphogenesis defects. This observation raises the interesting point that both a late loss and gain of Klf2a/Notch signaling causes comparable morphological defects in cardiac valve leaflet morphogenesis. We have now also included a short discussion of this point within the revised manuscript.</p><disp-quote content-type="editor-comment"><p>6) It would be beneficial to provide further support for the requirement of Krit1 for the generation of abluminal cell fates during valvulogenesis. The transient rescue of krit1 mutants allows AVC endocardial cells to differentiate properly at 48 hpf. Alcam levels do appear higher in most AVC cells at 96 hpf (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, duplicated in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4C</xref>’) but the morphology of the AV valve seems to also include abluminal cells (cardiac jelly cells or mesenchymal-like cells). Repeating the experiment in combination with a Wnt signaling readout (TCF reporter or other) and/or using the inducible hs:Krit1 line in the krit1 mutant background to better control krit1 levels, would strengthen their claim.</p></disp-quote><p>We agree with the reviewers on the need to provide additional markers for abluminal versus luminal fates in the rescue experiment. Due to the genetic complexity of setting up this rescue experiment, we have not been able to construct lines that also contain the Wnt reporter strain to show that abluminal fates are indeed absent/ suppressed. Also, the construction of a line for <italic>hs:</italic>Krit1 overexpression in that genetic background was not feasible. Unfortunately, constructing these lines would have exceeded the time allocated for these revisions by several months. Instead, we have now included data on Cdh5, another luminal fate marker. Using this additional marker, we now show that the late loss of Krit1 causes cells in abluminal positions to maintain high levels of Cdh5 while, in WT, Cdh5 is rapidly degraded within abluminal cells (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4C</xref>–C’’’). This finding is further supported by the finding that, in <italic>krit1</italic> mutants, Cdh5 levels are generally increased within endocardium (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B</xref>).</p><p>We have now removed all duplicated figures from the revised manuscript.</p><disp-quote content-type="editor-comment"><p>7) The model in <xref ref-type="fig" rid="fig5">Figure 5</xref> is somewhat confusing. It might be helpful to show a model for the ccm mutant with blood flow and then when there is no blood flow. Based on the authors' current model, it seems that Notch would be activated throughout the endocardium in the ccm mutant with blood flow since ccm is not present to block klf2a expression. If this is the case, this seems to be in conflict with the current ccm mutant and no blood flow model where the lack of blood flow would lead to no klf2a expression and downstream Notch signaling. Additionally, the authors also speculate &quot;Notch-mediated lateral inhibition&quot; in their model; however, there is insufficient data to support this notion. This should be modified in the model.</p></disp-quote><p>We agree with the reviewers that the speculation on “Notch-mediated lateral inhibition” should be removed from the model as shown in the revised <xref ref-type="fig" rid="fig5">figure 5</xref>. Importantly, Klf2a has two modes of induction as indicated in that model figure: 1). the physiological induction by blood flow and 2). a blood-flow independent suppression of expression by CCM proteins. Hence, the loss of CCM proteins causes Klf2a expression (and hence Notch1b expression) also in a blood-flow independent manner.</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The reviewers appreciate the improvements made in your revised manuscript, but they have also raised several issues that remain to be addressed through further revision, as outlined below.</p><p>1) The Abstract is confusing in its current form, as it is not made clear in which direction many of the genes/pathways mentioned affect outcome. As an example: does the abstract make it clear whether heg1 expression is increased or reduced by low blood flow? The last paragraph of the Introduction section is similarly vague and does not refer to the heg1 results.</p></disp-quote><p>The Abstract has been rephrased and clarified to clearly state that <italic>heg1</italic> is positively regulated by blood flow. The revised Abstract now states:</p><p>“We find that the expression of <italic>heg1</italic>, which encodes a binding partner of Krit1, is positively regulated by blood flow. In turn, Heg1 stabilizes levels of Krit1 protein and both, Heg1 and Krit1, dampen expression levels of <italic>klf2a</italic>, a major mechanosensitive gene which is a regulator of <italic>notch1b</italic>. Conversely, loss of Krit1 results in increased expression of <italic>klf2a</italic> and <italic>notch1b</italic> throughout the endocardium and also prevents endocardial sprouting which is required for cardiac valve leaflet formation.”</p><p>Similarly, the last paragraph of the Introduction section has been clarified:</p><p>“We find that expression of <italic>heg1</italic> is positively regulated in response to blood flow and <italic>klf2a</italic>/b. We also explored the role of Heg1 and Krit1 in Klf2-dependent endothelial mechanotransduction during the formation of cardiac valve leaflets. Here, we show that Krit1 dampens levels of <italic>klf2a</italic> and <italic>notch1b</italic> expression. In tune with this finding, loss of Krit1 results in the strong expression of <italic>klf2a</italic> and <italic>notch1b</italic> within the endocardium and prevents the formation of an abluminal population of valve leaflet cells from endocardial cushions.”</p><disp-quote content-type="editor-comment"><p>2) In the Title, it may be better to mention CCM1/2, since CCM3 is not addressed in this study. Non-CCM experts may not appreciate what &quot;CCM proteins&quot; are.</p></disp-quote><p>The title has been changed to explicitly refer to Heg1 and Ccm1/2.</p><disp-quote content-type="editor-comment"><p>3) From the data shown in the revised manuscript, it is not clear whether heg1 is expressed in the endocardium or the myocardium, although it is stated that it is expressed in the endocardium. Can the evidence for this be clarified?</p></disp-quote><p>The endocardial expression has been described by Mably et al., 2003 (Figure 7B). Within the revised manuscript, we now also include an improved <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref> which shows that <italic>heg1</italic> expression is strongly reduced in <italic>tnnt2a</italic> morphants that lack blood flow. This finding is in tune with a blood flow-dependent regulation of <italic>heg1</italic> within the endocardium.</p><disp-quote content-type="editor-comment"><p>4) The use of the Notch reporter, in place of the previous Flt reporter, to monitor flow response is appreciated. However, the images in <xref ref-type="fig" rid="fig2">Figure 2B–D</xref> are hard to interpret. Although the ratios measured by the authors (<xref ref-type="fig" rid="fig2">Figure 2E–F</xref>) demonstrate the same trend following overexpression of Krit1 and Ccm2, the patterns of expression shown in <xref ref-type="fig" rid="fig2">Figure 2C–D</xref> seem markedly different; hard to interpret. This apparent discrepancy should be addressed. In addition, in light of recent studies showing myocardial Notch reporter activity in developing zebrafish hearts, it is unclear whether the Notch reporter activity shown here (and in <xref ref-type="fig" rid="fig4">Figure 4</xref>) is endocardial or myocardial. Can this be clarified?</p></disp-quote><p>We apologize for the previous figure which has been misleading with respect to the expression of Notch activity in hs:Ccm2 conditions. Within the revised version of the manuscript, we have now exchanged, within <xref ref-type="fig" rid="fig2">Figure 2D, a</xref> more representative subfigure of the <italic>hs:</italic>Ccm2 condition which is similar to hs:<italic>Krit1</italic> (which is also supported by the quantifications shown in subfigures <xref ref-type="fig" rid="fig2">Figure 2E,F</xref>. The strong downregulation of Notch activity upon activation of Krit1 or <italic>ccm2</italic> is also strikingly visible in a new <xref ref-type="fig" rid="fig1">Figure 2—figure supplement 1</xref>. Notably, the expression of this Notch reporter was exclusively endocardial in all of these experimental conditions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>).</p><disp-quote content-type="editor-comment"><p>5) The authors utilize Cdh5 as a marker for the lumenal side of the AV valve, but they do not cite references for its use as a lumenal marker. If they are introducing this marker here, its characterization as such should be clearly described.</p></disp-quote><p>Within the revised manuscript, we have referenced the work of Steed et al., 2016 which has first described Cdh5 as a luminal marker at the AVC valves whereas the protein is lost from the membrane on the abluminal side of the cardiac valve leaflets. This has been shown in Steed et al., 2016, <xref ref-type="fig" rid="fig3">Figure 3</xref> and in the model thereof.</p><disp-quote content-type="editor-comment"><p>6) In <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, the authors use a single marker (Myh6) to define the location of the AVC in krit1 mutants. This marker indicates the edge of the atrium but isn't sufficient to demonstrate whether the AVC is or isn't expanded in the mutant hearts. Can the authors use specific AVC markers to indicate whether the AVC region is expanded in krit1 mutants?</p></disp-quote><p>Within the revised version of the manuscript, we have now included a figure showing a whole-mount in situ hybridization against tbx2b, which is a marker of the AVC region (shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C–D</xref>). We conclude:</p><p>“In comparison, the expression of <italic>tbx2b</italic>, another AVC marker gene (Sedletcaia and Evans, 2011), was not expanded in <italic>ccm2<sup>m201</sup></italic>mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C–D</xref>). Hence, the expansion of the <italic>notch1b</italic> expression domain in <italic>krit1</italic> or <italic>ccm2</italic> mutants is not due to a regional expansion of the AVC.”</p><disp-quote content-type="editor-comment"><p>7) At the beginning of the Discussion section, the authors allude to evidence that Cdh5/VEcadherin plays into this pathway, but such evidence is not reported in this manuscript.</p></disp-quote><p>We apologize for this error which has been corrected within the revised version of the manuscript.</p><disp-quote content-type="editor-comment"><p>8) The new model figure is appreciated, but, in light of what is suggested by <xref ref-type="fig" rid="fig1">Figure 1</xref>, it does not address the effect of flow on Heg1 and Krit1 levels. This is confusing – can it be revised to include these elements of the model?</p></disp-quote><p>We have now adjusted model <xref ref-type="fig" rid="fig5">Figure 5</xref> to show that the expression of CCM proteins is positively regulated by blood flow and Klf2. We also show that the expression of <italic>klf2a</italic> is affected by blood flow (this activation is dampened by CCM proteins) and that there is another blood flow-independent mechanism of Klf2 activation that is inhibited by CCM proteins in WT. Upon loss of CCM proteins, a blood-flow independent activation of <italic>klf2</italic> expression throughout the endocardium inhibits endocardial sprouting of cardiac valve leaflet cells. Within the revised figure legend, we state:</p><p>“Ccm proteins provide a bias in Klf2a and Notch expression levels. Some cells that express lower levels of <italic>klf2a</italic> expression and have a lower Notch activity establish protrusions and migrate into the cardiac jelly (endocardial sprouting). In <italic>ccm</italic> mutants, endocardial cells overexpress <italic>klf2a</italic> and have a higher Notch activity due to a blood flow-independent mechanism. As a consequence, high levels of Notch activity throughout the entire endocardium result in a failure of endocardial sprouting.”</p></body></sub-article></article>